Vascular disorder
MONDO:0005385A general term used to describe any disease affecting blood vessels]. It includes vascular abnormalities caused by degenerative, metabolic and inflammatory conditions, embolic diseases, coagulative disorders, and functional disorders such as posteri or reversible encephalopathy syndrome.
Also known as: disease of vasculature, disease or disorder of vasculature, disorder of vasculature, vascular disorder, vasculature disease, vasculature disease or disorder, vasculopathy
10075 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 3856 trials in this tab.
-
A drug that protects the liver may make stem cell transplants safer for children with sickle cell disease
⭐️ CURE ⭐️ Recruiting nowThis trial tests whether giving defibrotide before and after a stem cell transplant can prevent a serious liver condition called sinusoidal obstructive syndrome (SOS) in children and young adults with sickle cell disease or beta thalassemia. Participants receive defibrotide start…
Phase: PHASE2 • Sponsor: New York Medical College • Aim: ⭐️ CURE ⭐️
Last updated Jul 29, 2026 00:00 UTC
-
New device aims to clear lung clots fast
Disease control Recruiting nowThis study will test a device called EkoSonic in 30 Chinese patients with acute pulmonary embolism (blood clots in the lungs). The device uses ultrasound to help break up clots while delivering clot-busting medicine. The main goal is to see if it improves heart function within 48…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Could an inhaled sedative quiet the Brain's migraine alarm?
Disease control Recruiting nowThis trial tests whether inhaling a sedative called dexmedetomidine can reduce the brain's oversensitivity that drives chronic migraine. Researchers will measure changes in pain-related biomarkers and nerve signals in people with early chronic migraine. The goal is to see if this…
Phase: NA • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
New radiation approach before surgery for rare adrenal cancer
Disease control Recruiting nowThis early-phase trial tests giving radiation therapy before surgery to people whose adrenal cancer has come back. The goal is to find a safe radiation dose and see if it helps shrink tumors before removal. About 32 adults with resectable recurrent ACC will receive daily radiatio…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Can a new heart valve match the safety of proven ones?
Disease control Recruiting nowThis trial tests whether a new transcatheter heart valve (Myval) works as safely and effectively as two existing valves (Sapien and Evolut) in people with severe aortic stenosis, a condition where the heart's main valve narrows. About 768 patients who are eligible for valve repla…
Phase: NA • Sponsor: Meril Life Sciences Pvt. Ltd. • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
New drug aims to stop nosebleeds in rare blood vessel disorder
Disease control Recruiting nowThis study tests an experimental drug called ATV-1601 in people with moderate to severe HHT, a condition that causes frequent nosebleeds and anemia. The trial has two parts: first, participants receive either the drug or a placebo to check safety and effectiveness; then, all elig…
Phase: PHASE1, PHASE2 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Old drug, new hope? spironolactone trial targets lung blood vessel damage
Disease control Recruiting nowThis phase 2 study tests whether spironolactone, a drug already used for fluid retention, can improve exercise capacity and blood vessel function in people with pulmonary arterial hypertension (PAH). About 70 adults with PAH will receive either spironolactone or a placebo for 24 …
Phase: PHASE2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
New eye drug aims to stop diabetic vision loss
Disease control Recruiting nowThis early-stage trial tests an experimental drug called RO7663498, given as an injection into the eye, for people with diabetic retinopathy. The main goal is to check safety and how the drug moves through the body. About 30 participants will receive multiple doses to see if it i…
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Heart patients may need only one blood thinner after balloon treatment, major trial tests
Disease control Recruiting nowThis study looks at whether taking just one blood thinner (a P2Y12 inhibitor) is as safe and effective as taking two blood thinners (dual antiplatelet therapy) for people with stable heart disease who have a drug-coated balloon procedure without a stent. About 2,170 adults will b…
Phase: NA • Sponsor: Gan Lijun • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Could a simple scan replace invasive heart imaging before bypass surgery?
Disease control Recruiting nowThis trial tests whether planning coronary artery bypass grafting (CABG) using a non-invasive CT scan (CCTA) works as well as the standard invasive angiography (CAG). About 826 people with blocked heart arteries will be randomly assigned to have their surgery planned with one of …
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
New stent graft for aortic arch disease tracked for 10 years
Disease control Recruiting nowThis study follows 125 people who received a special stent graft (GORE TAG TBE) to treat a tear or bulge in the main artery near the heart (aortic arch). The goal is to see how well the device works and how safe it is over 5 to 10 years. Participants are treated as part of their …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Virtual reality could help stroke survivors walk again in the real world
Disease control Recruiting nowThis study tests a new virtual reality (VR) walking therapy for people who have had a stroke within the past 1 to 6 months. Participants will use either a fully immersive VR system that lets them walk over ground in realistic environments, or a semi-immersive VR system on a tread…
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Can a new injection ease heart and lung strain in obesity?
Disease control Recruiting nowThis trial is testing an experimental drug called HS235 in obese adults who have both pulmonary hypertension and heart failure with preserved ejection fraction. The study aims to see if the drug is safe, how it moves through the body, and whether it can improve heart and lung fun…
Phase: PHASE1, PHASE2 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Can a new injection slow pulmonary arterial hypertension?
Disease control Recruiting nowThis trial is testing an experimental drug called HS235, given as a shot under the skin, in adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes it hard to breathe and can strain the heart. The study aims to see if adding HS2…
Phase: PHASE1, PHASE2 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Sound wave device aims to crack hardened heart arteries
Disease control Recruiting nowThis first-in-human study tests a new device called Pulse IVL that uses sound waves to break up calcium buildup in heart arteries. Up to 15 people with coronary artery disease will receive the treatment before getting a stent. The goal is to see if the device is safe and helps op…
Phase: NA • Sponsor: Amplitude Vascular Systems, Inc. • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Electric jolt workouts: a new hope for paralyzed limbs?
Disease control Recruiting nowThis study tests whether exercise using electrical stimulation can improve muscle strength and endurance in people with lower limb paralysis from conditions like spinal cord injury, stroke, or multiple sclerosis. Participants will use devices that send electrical signals to their…
Phase: NA • Sponsor: Louis Stokes VA Medical Center • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Twice-Yearly shot aims to cut heart attacks and amputations
Disease control Recruiting nowThis study tests whether inclisiran, a twice-yearly injection that lowers cholesterol, can prevent major heart and limb events in 6,000 people who recently had artery-opening procedures. Participants receive either inclisiran or a placebo shot at the start, at 90 days, and every …
Phase: PHASE4 • Sponsor: Duke University • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Can a Clot-Removal procedure turn the tide in severe stroke?
Disease control Recruiting nowThis trial is investigating whether adding a clot-removal procedure, called endovascular treatment, to standard medical care can improve outcomes for people who have had a severe stroke caused by a blockage in the basilar artery, a major vessel at the back of the brain. The study…
Phase: NA • Sponsor: The First Affiliated Hospital of Hainan Medical University • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Can video games rebuild arm strength after a stroke?
Disease control Recruiting nowThis trial tests whether a computer-based rehabilitation system called NeuroTechR3 can help people improve arm and hand function after a stroke. Participants will play upper extremity rehabilitation games on a computer for 30 minutes, three times a week. The study measures change…
Phase: NA • Sponsor: Brooks Rehabilitation • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
New heart valve replacement could help thousands avoid Open-Heart surgery
Disease control Recruiting nowThis study tests a new device called the VDyne System, which is placed inside the heart through a tube in a blood vessel to replace a leaky tricuspid valve. The trial will include 730 people with severe symptoms who have not improved with medication. Researchers will compare the …
Phase: NA • Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC
-
Brain bleed breakthrough? new trial tests early surgery against standard care
Disease control Recruiting nowThis study looks at whether doing a small surgery early to remove blood from a deep brain bleed helps patients more than standard medical care. About 600 adults aged 18 to 70 with a specific type of brain bleed will take part. The goal is to see which approach leads to better rec…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Which route to the vein works best for varicocele repair?
Disease control Recruiting nowThis trial is testing two different ways to perform varicocele embolization, a procedure that blocks off enlarged veins in the scrotum to relieve pain and improve fertility. Thirty men with varicocele will receive the procedure either through a vein in the neck (transjugular) or …
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a daily pill stop migraines in kids? new trial aims to find out
Disease control Recruiting nowThis phase 3 trial is testing atogepant, a daily pill already approved for adults, to prevent episodic migraines in children aged 6 to 17. About 450 participants will receive either a low or high dose of the drug or a placebo for 12 weeks. The goal is to see if it safely reduces …
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Robot amplifies stroke Survivors' steps to boost balance
Disease control Recruiting nowThis study explores whether a robotic device that amplifies a person's own walking movements can help improve balance in people who have had a stroke. Participants with chronic stroke (more than 6 months ago) will do two treadmill walking sessions—one in a normal environment and …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Gene therapy shot aims to stop diabetic eye disease in its tracks
Disease control Recruiting nowThis study tests a one-time gene therapy called surabgene lomparvovec (Sura-vec) for diabetic retinopathy, a common eye problem from diabetes that can lead to blindness. About 576 adults with moderate-to-severe non-proliferative diabetic retinopathy will receive either the gene t…
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could yearly Low-Energy laser replace daily eye drops for glaucoma?
Disease control Recruiting nowThis study looks at whether a gentle laser treatment (SLT) works as well as the standard version for people with glaucoma or high eye pressure. It also tests if getting the gentle laser once a year can delay or prevent the need for daily eye drops. About 790 adults will take part…
Phase: PHASE3 • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New heart stent under review in 3,000-Patient study
Disease control Recruiting nowThis study is checking how well a new drug-coated stent (Coroflex ISAR NEO) works in people with coronary artery disease. Researchers will follow 3,000 patients who get the stent during a routine procedure to see if it keeps arteries open safely. The goal is to confirm the stent …
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Sound wave device zaps artery calcium, could save limbs
Disease control Recruiting nowThis study is testing a device that uses sound waves to break up calcium buildup in the leg arteries of people with peripheral artery disease. The goal is to improve blood flow, reduce pain, and help people walk better. About 50 participants will be followed for one year to see i…
Sponsor: Yale University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New eye drug combo aims to tackle Diabetes-Related vision loss
Disease control Recruiting nowThis early-stage trial tests an experimental drug called RO7823653, given as an eye injection alone or with an approved drug (faricimab), for people with diabetic macular edema—a condition where diabetes causes fluid buildup and vision loss in the center of the eye. The study wil…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New drug avacopan under Long-Term safety review for vasculitis patients
Disease control Recruiting nowThis study is checking the long-term safety of a drug called avacopan for people with ANCA-associated vasculitis, a rare disease where the immune system attacks blood vessels. About 300 adults who need treatment for a new diagnosis or flare-up will take avacopan or a placebo. The…
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Less invasive heart valve replacement put to the test against Open-Heart surgery
Disease control Recruiting nowThis study compares two standard procedures—minimally invasive TAVR and open-heart surgery (SAVR)—for replacing a diseased aortic valve in people with a bicuspid aortic valve. About 1,200 participants aged 50 and older with severe aortic stenosis will be randomly assigned to one …
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a stem cell transplant tame tough scleroderma?
Disease control Recruiting nowThis study tests a stem cell transplant using the patient's own blood cells to treat severe scleroderma (systemic sclerosis) that hasn't improved with standard drugs. The goal is to see if this high-dose therapy is safe and can stop the disease from getting worse. The trial enrol…
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for CLL patients with weak hearts: acalabrutinib under the microscope
Disease control Recruiting nowThis study tests the drug acalabrutinib in people with chronic lymphocytic leukemia (CLL) who also have moderate to severe heart failure. Researchers want to see if acalabrutinib causes fewer heart-related side effects compared to other standard treatments. About 60 adults will t…
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New stroke drug TAK-755 enters human trials – could improve recovery
Disease control Recruiting nowThis phase 2 trial is testing whether TAK-755, a lab-made protein that helps break up blood clots, is safe and effective for people who have had an acute ischemic stroke. About 222 adults aged 18 to 80 will receive either TAK-755 or a placebo, along with standard stroke care, and…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a stent double the chance of a good recovery after severe stroke?
Disease control Recruiting nowThis trial tests whether placing a stent in a narrowed or blocked neck artery during emergency stroke treatment helps people recover better than just removing the clot in the brain. About 15-20% of severe strokes involve both a brain clot and a neck artery blockage. The study wil…
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New antibody aims to shield kidneys from autoimmune attack
Disease control Recruiting nowThis Phase 2 trial tests whether adding ALE.F02 to standard therapy can protect kidney function in people with ANCA-associated vasculitis, an autoimmune disease that attacks small blood vessels, often damaging the kidneys. About 80 participants will receive either a low, high, or…
Phase: PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New shot aims to lower blood pressure for months
Disease control Recruiting nowThis study tests a single dose of an experimental drug called ALN-AGT01 in adults with mild to moderate high blood pressure who have already been treated with another drug, zilebesiran. The goal is to see if it safely helps control blood pressure by measuring changes in blood pre…
Phase: PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New inhaled drug aims to help lung patients breathe and move easier
Disease control Recruiting nowThis phase 3 trial tests an inhaled drug called treprostinil palmitil in 344 adults with pulmonary hypertension caused by interstitial lung disease. Participants take the drug or a placebo once daily for 24 weeks. The main goal is to see if the drug helps them walk farther in six…
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Second Time's the charm? new study tests replacing heart valves again without surgery
Disease control Recruiting nowThis study follows 550 patients whose first TAVI heart valve has failed. Researchers will compare a second TAVI procedure (redo TAVI) with open-heart surgery or medication alone. The goal is to see which approach works best and why, helping doctors make better decisions for futur…
Sponsor: The Leeds Teaching Hospitals NHS Trust • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
10-Year study tracks stent graft safety in 1,500 aortic patients
Disease control Recruiting nowThis study follows 1,500 people who received a GORE® TAG® stent graft to treat aortic conditions like aneurysms or dissections. Researchers will monitor device performance and patient outcomes for up to 10 years. The goal is to confirm that this minimally invasive procedure remai…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could a diabetes pill strengthen the right heart in lung hypertension?
Disease control Recruiting nowThis study tests whether empagliflozin, a diabetes medicine, can improve right heart function in 78 adults with pulmonary arterial hypertension (PAH). Participants continue their usual PAH treatments and receive either empagliflozin or a placebo. The main goal is to see if the dr…
Phase: PHASE2 • Sponsor: Gustavo A Heresi, MD, MS • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New heart valve replacement could spare patients from major surgery
Disease control Recruiting nowThis study tests a new device called the VDyne System, which is placed through a tube in a blood vessel to replace the tricuspid valve in the heart. It is for people with severe tricuspid regurgitation, a condition where the valve does not close properly, causing blood to leak ba…
Phase: NA • Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a higher dose of adenosine sharpen heart scans?
Disease control Recruiting nowThis trial is testing whether a higher dose of adenosine, a drug used during cardiac MRI to stress the heart, improves blood flow imaging compared to the standard dose. The study includes 180 adults with suspected or known coronary artery disease or heart failure. By comparing th…
Phase: PHASE4 • Sponsor: Region Skane • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could stem cells help stroke patients recover? new trial launches
Disease control Recruiting nowThis study tests a single injection of stem cells (B2065) given within 36 hours of a stroke. The goal is to see if it is safe and might help patients recover better. Fifty-four adults with moderate to severe stroke will receive either the stem cells or a placebo, and be followed …
Phase: PHASE1, PHASE2 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can exercise boost reading recovery in stroke survivors?
Disease control Recruiting nowThis trial tests whether combining aerobic exercise with a targeted reading therapy, called Phono-Motor Therapy, can improve reading skills in people who have reading difficulties after a stroke. Participants will receive both interventions, and researchers will measure changes i…
Phase: NA • Sponsor: Kessler Foundation • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Inhaled drug tested for long-term safety in lung-related high blood pressure
Disease control Recruiting nowThis phase 3 study tests the long-term safety of an inhaled drug called treprostinil palmitil for people with pulmonary hypertension caused by interstitial lung disease. About 344 adults who completed an earlier trial will take the drug for up to 2 years. Researchers will track s…
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a stent heal leg ulcers that Won't close?
Disease control Recruiting nowThis study tests whether placing a stent in a blocked pelvic vein can help heal chronic leg ulcers in people with post-thrombotic syndrome, a complication of deep vein thrombosis. Twenty adults with non-healing venous ulcers will receive the stenting procedure plus standard ulcer…
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug aims to tame rare blood vessel disease
Disease control Recruiting nowThis Phase 3 trial is testing whether adding BDB-001 to standard treatments (cyclophosphamide, azathioprine, rituximab, or prednisone) helps more people with ANCA-associated vasculitis achieve remission. The study plans to enroll 300 adults with active GPA or MPA. Participants wi…
Phase: PHASE3 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New device aims to tackle deadly lung clots
Disease control Recruiting nowThis study is testing a device called FlowTriever that removes blood clots from the lungs in people with a severe, high-risk pulmonary embolism. About 200 participants will be randomly assigned to get either the device or standard care. The goal is to see if the device reduces de…
Phase: NA • Sponsor: Inari Medical • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Shorter blood thinner combo may cut bleeding risk in heart patients
Disease control Recruiting nowThis study tests whether a personalized blood-thinner plan can reduce bleeding in people with coronary artery disease who have received a heart stent. About 3,944 participants will either get the usual dual antiplatelet therapy (two blood thinners) or a shorter course followed by…
Phase: PHASE4 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Doctor-Tailored stent graft aims to tame deadly aortic aneurysms
Disease control Recruiting nowThis study tests a stent graft that doctors modify to fit each patient's unique aneurysm in the chest and abdomen. The goal is to see if this less invasive approach is as safe and effective as traditional open surgery. About 80 people aged 50 and older with large aneurysms will t…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Melatonin may tame blood pressure during menopause transition
Disease control Recruiting nowThis study looks at whether taking melatonin for 12 weeks can help lower blood pressure in women going through menopause who already have high blood pressure. Researchers will measure nighttime blood pressure and check for changes in stress markers. The goal is to find a simple, …
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New balloon treatment for heart disease under real-world watch
Disease control Recruiting nowThis study is a registry that follows about 960 people with coronary artery disease who are treated with a special balloon coated with a drug called sirolimus. The balloon is used to open blocked heart arteries. Researchers will track heart-related events like death, heart attack…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New shot may slash cholesterol right after a heart attack
Disease control Recruiting nowThis study tests whether starting inclisiran early during a hospital stay for a heart attack can lower bad cholesterol more than a placebo, when both are added to standard care. About 300 adults hospitalized for a heart attack will receive either inclisiran or a placebo shot at t…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Talking it out: could motivational interviewing lower blood pressure?
Disease control Recruiting nowThis trial tests whether nurse-led motivational interviewing—a counseling style that helps people find their own motivation to change—can improve blood pressure control in adults with hypertension. Participants are randomly assigned to usual care, individual counseling, or counse…
Phase: NA • Sponsor: Kutahya Health Sciences University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a Clot-Removing device shield the Brain's thinking power after stroke?
Disease control Recruiting nowThis study looks at whether successfully restoring blood flow in the brain using the Tigertriever device, a tool that removes clots during a stroke, may also help protect cognitive abilities like memory and attention. Researchers will follow 424 adults aged 18 to 75 who had a lar…
Sponsor: Rapid Medical • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New trial aims to protect Moms' hearts after preeclampsia
Disease control Recruiting nowThis trial tests a 9-month program for women who had preeclampsia during their first pregnancy. The program includes online screening, group meetings, and a smartphone app to help monitor blood pressure and weight. Researchers want to see if it improves heart health and promotes …
Phase: NA • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Home blood pressure monitoring: which delivery and training method works best?
Disease control Recruiting nowThis study compares different ways to give blood pressure cuffs and training to adults with uncontrolled high blood pressure during routine primary care visits. Participants receive a cuff either in the clinic or by mail, and training either hands-on or through written instructio…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Timing is everything: could physiotherapy minutes after extubation prevent lung complications?
Disease control Recruiting nowThis trial tests whether starting respiratory physiotherapy within one hour of breathing tube removal after elective coronary artery bypass surgery improves lung function and reduces complications compared to waiting until the next day. Forty adults undergoing planned heart surge…
Phase: NA • Sponsor: Dijana Filipović • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a simple algorithm help doctors write better exercise prescriptions?
Disease control Recruiting nowThis study tests a new digital tool called P3-EX that helps doctors create personalized exercise plans for patients with heart disease risk factors like high blood pressure, diabetes, and obesity. Researchers will recruit 24 doctors and 48 patients to compare the new tool with a …
Phase: NA • Sponsor: University of Connecticut • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New device for brain aneurysms under Real-World watch
Disease control Recruiting nowThis study follows 118 people getting a special device called Pipeline Vantage to treat brain aneurysms. The device is placed inside the blood vessel to block the aneurysm and prevent rupture. Researchers will check how well it works and if there are any problems one year after t…
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New virus therapy takes on advanced cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called MQ710, a modified virus injected directly into tumors, alone or with the immunotherapy drug pembrolizumab. It is for people with advanced solid tumors (like skin cancer or head and neck cancer) that have not responded to standar…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New heart valve procedure could offer safer alternative to Open-Heart surgery for seniors
Disease control Recruiting nowThis study tests whether a newer, less invasive procedure called transcatheter aortic valve replacement (TAVR) using the J-VALVE device is as safe and effective as traditional open-heart surgery for people with severe aortic regurgitation (a leaky heart valve). About 1,250 adults…
Phase: NA • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Implantable device could offer new hope for patients with untreatable chest pain
Disease control Recruiting nowThis trial tests an implantable device called the Shockwave Reducer for people with severe, persistent chest pain (refractory angina) who cannot have standard treatments like stents or bypass surgery. About 380 participants will either receive the device or a sham procedure. The …
Phase: NA • Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New Stent-Graft aims to fix aneurysms without cutting off blood flow
Disease control Recruiting nowThis early trial tests a new device called the iHub stent-graft in 10 adults with iliac artery aneurysms. The device is placed through a small incision to seal off the aneurysm while keeping blood flowing to the internal iliac artery. Researchers will check for serious problems w…
Phase: NA • Sponsor: Archo Medical S.A • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New oral option may offer relief for hereditary angioedema attacks
Disease control AVAILABLEThis program provides access to an experimental oral medication called deucrictibant for people with hereditary angioedema (HAE) who have no satisfactory alternative treatments for acute attacks. Eligible participants, aged 12 to 75, take the capsule as needed to manage swelling …
Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a gentle ear zap wake the brain after a bleed?
Disease control Recruiting nowThis trial tests whether a gentle electrical stimulation applied to the ear—called transcutaneous auricular vagus nerve stimulation—can help people recover consciousness after surgery for a spontaneous brain hemorrhage. The study will include 160 adults aged 18 to 75 who remain i…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New device zaps kidney nerves to lower blood pressure in Real-World study
Disease control Recruiting nowThis study is tracking 1,000 patients with high blood pressure who receive the Paradise Ultrasound Renal Denervation treatment. The procedure uses ultrasound energy to calm overactive nerves near the kidneys, which can help lower blood pressure. Researchers are monitoring blood p…
Sponsor: ReCor Medical, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New balloon could improve treatment for blocked leg arteries
Disease control Recruiting nowThis study compares a new balloon coated with everolimus to standard paclitaxel-coated balloons for opening blocked leg arteries in people with peripheral artery disease. About 410 participants will be randomly assigned to one of the two balloons. The goal is to see if the new ba…
Phase: NA • Sponsor: Cook Research Incorporated • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New heart device for babies: safer alternative to surgery?
Disease control Recruiting nowThis study follows 255 patients of any age (weighing over 3 kg) who receive a device called the Occlutech PDA Occluder to close a common heart defect called patent ductus arteriosus (PDA). The device is inserted through a blood vessel, avoiding open-heart surgery. Researchers wil…
Sponsor: Occlutech International AB • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug targets root cause of rare overgrowth syndromes
Disease control Recruiting nowThis Phase 2 study tests an oral drug called RLY-2608 in adults and children with overgrowth conditions (like CLOVES or Klippel-Trenaunay syndrome) caused by PIK3CA gene mutations. The drug is designed to block the faulty protein driving abnormal tissue growth. The trial will enr…
Phase: PHASE2 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Spinal implant may tackle pain and blood pressure together
Disease control Recruiting nowThis study looks at whether spinal cord stimulation, a device already used for chronic pain, can also reduce blood pressure in people with hypertension and low back pain. Researchers will measure blood pressure changes and pain levels, and explore how different stimulation patter…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can training the brain to think about words boost recovery from stroke-related aphasia?
Disease control Recruiting nowThis trial tests whether adding metacognitive training—exercises that help people think about their own thinking—to standard word-finding rehabilitation can improve language skills in people with chronic aphasia after a stroke. The study involves 18 participants who will receive …
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New minimally invasive procedure could change outcomes for bleeding stroke patients
Disease control Recruiting nowThis study compares standard medical care to a new, less invasive surgery for people with a severe bleeding stroke. The surgery uses a small tube to drain the blood clot and delivers clot-busting medicine directly into the brain. Researchers want to see if this approach helps pat…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Weekly shot could replace daily growth hormone for kids
Disease control Recruiting nowThis phase 3 trial compares a once-weekly growth hormone injection (lonapegsomatropin) to a daily one (somatropin) in 186 prepubertal children with growth failure due to Turner syndrome, SHOX deficiency, being small for gestational age, or idiopathic short stature. The goal is to…
Phase: PHASE3 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a Low-Dose clot buster boost recovery after stroke clot removal?
Disease control Recruiting nowThis trial investigates whether giving a low dose of the clot-busting drug alteplase directly into the brain artery, right after successful mechanical clot removal, can improve recovery in people with a severe stroke caused by a large vessel blockage. About 416 adults who have ha…
Phase: PHASE3 • Sponsor: 115 People's Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New heart valve could save lives without Open-Heart surgery
Disease control Recruiting nowThis trial is testing a new heart valve called SAPIEN X4/X4S in over 1,200 people with severe aortic stenosis, a condition where the heart's aortic valve narrows. The valve is inserted through a catheter, avoiding open-heart surgery. Researchers are measuring how many patients di…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug hopes to ease breathing and heart strain in lung disease patients
Disease control Recruiting nowThis study tests a drug called mirivadelgat in people with high blood pressure in the lungs caused by lung scarring (PH-ILD). The goal is to see if it improves blood flow in the lungs, exercise ability, and overall well-being. About 126 participants will take the drug or a placeb…
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
CRISPR injection could rewrite the future of blood pressure control
Disease control Recruiting nowThis trial tests an experimental therapy called CTX340, which uses CRISPR gene editing to disable a gene in the liver that regulates blood pressure. It is designed for adults with uncontrolled hypertension despite taking multiple blood pressure medications. The study will first a…
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Turning stroke recovery into a game: can a knob controller restore hand dexterity?
Disease control Recruiting nowThis trial tests whether adding self-administered hand therapy at home, using a videogame controller called the Twirlstone, can improve hand dexterity and coordination in stroke survivors. Participants, who are within six weeks of a stroke and have arm or hand weakness, will eith…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could treating mild hypertension in pregnancy help babies?
Disease control Recruiting nowThis study tests whether treating mild high blood pressure (stage 1 hypertension) during pregnancy can improve baby birth weight. 74 pregnant people with blood pressure between 130-139/80-89 mmHg will be randomly assigned to either active treatment with blood pressure medication …
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug aims to protect dialysis Patients' hearts
Disease control Recruiting nowThis study tests a drug called CSL300 in people with end-stage kidney disease who are on dialysis and have signs of inflammation. The goal is to see if it can reduce the risk of heart attacks or heart-related death. About 3110 adults will take part, and half will get the drug whi…
Phase: PHASE2, PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a gentle ear zap calm the Brain's overactive 'Fight or Flight' response?
Disease control Recruiting nowThis trial tests whether a non-invasive device that stimulates the vagus nerve through the ear can reduce harmful spasms in brain arteries that often occur days after an aneurysm rupture. The study will enroll 10 adults who have had this type of bleeding in the brain and will rec…
Phase: NA • Sponsor: Marshall Holland • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a simple drug combo stop heart disease before it starts?
Disease control Recruiting nowThis study will screen 1,500 people with early signs of heart disease (plaque in arteries) to see if two common drugs—rosuvastatin and colchicine—can reduce or stabilize that plaque over two years. Participants will take pills daily and get heart-healthy lifestyle advice. The goa…
Phase: PHASE3 • Sponsor: Duke University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New device aims to unclog stents in leg veins
Disease control Recruiting nowThis study tests a new device called the RevCore Thrombectomy Catheter to treat blocked stents in the leg veins. About 100 adults with stents that have been in place for at least 6 weeks will be enrolled. The device is inserted into the vein to remove the blockage and restore blo…
Sponsor: Inari Medical • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug BBD-1 shows promise for painful skin and kidney disease
Disease control Recruiting nowThis study tests a new drug, BBD-1, against standard steroids for IgA vasculitis, a disease that causes purple spots on the skin, joint pain, and can damage the kidneys. The trial will enroll 30 adults with confirmed IgA vasculitis. The goal is to see if BBD-1 can clear skin spot…
Phase: PHASE2 • Sponsor: Qifeng Zhang • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a tailored Blood-Thinner combo prevent second heart attacks without causing bleeding?
Disease control Recruiting nowThis trial tests whether adding a low-dose blood thinner (rivaroxaban) to standard antiplatelet therapy for the first three months after a heart stent procedure can reduce the risk of future heart attacks, strokes, and other cardiovascular events in high-risk patients. Participan…
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Heart valve study seeks best blood thinner to prevent clots and bleeding
Disease control Recruiting nowThis study tests two blood-thinning strategies in people with severe aortic regurgitation who have had a new heart valve placed without open surgery. Participants receive either daily aspirin for a year or warfarin for six months followed by aspirin. The goal is to see which appr…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can combined Arm-Leg training rebuild balance after stroke?
Disease control Recruiting nowThis study tests whether a structured rehabilitation program called HABIT-ILE, which combines intensive arm, hand, and leg exercises, can improve balance and coordination in people recovering from a stroke. The trial will include 44 stroke survivors aged 40 to 60, who will be ran…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Giant cell arteritis patients may be able to reduce treatment, study suggests
Disease control Recruiting nowThis study looks at whether people with giant cell arteritis (GCA) who are in remission can safely stop or lower their dose of tocilizumab (Actemra). About 78 adults who have been on high-dose tocilizumab for at least a year and off steroids for three months will either stop the …
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Which brain aneurysm treatment is safer? a Head-to-Head test
Disease control Recruiting nowThis study compares two procedures used to treat unruptured wide-neck brain aneurysms: flow diverter stents and stent-assisted coiling. Researchers will follow 274 adults from three centers in China who receive one of these treatments as part of routine care. The main question is…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for PAH patients: Long-Term sotatercept trial launches
Disease control Recruiting nowThis long-term study follows people with pulmonary arterial hypertension (PAH) who previously took part in sotatercept trials. Sotatercept is a targeted therapy that aims to stop PAH from getting worse. Researchers will monitor safety, side effects, and how well patients tolerate…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New device aims to seal brain aneurysms and prevent strokes
Disease control Recruiting nowThis study is testing a device called a flow modulator to treat wide-necked brain aneurysms. The device is placed inside the artery to redirect blood flow away from the aneurysm, helping it close off. Researchers will check if the device is safe and effective in 214 adults over 1…
Phase: NA • Sponsor: phenox Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Which blood thinner is safer for heart patients? a Head-to-Head test
Disease control Recruiting nowThis trial compares two blood thinners, edoxaban and apixaban, in people who have both atrial fibrillation (an irregular heartbeat) and coronary artery disease (narrowed heart arteries). Both drugs help prevent blood clots, but they are taken differently and may have different ri…
Phase: PHASE4 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New balloon tackles tough heart blockages in major registry
Disease control Recruiting nowThis study looks at how a special balloon called the OPN balloon is used to open severely hardened or blocked heart arteries. Researchers will track 300 adults who need this procedure to see how well it works and what problems might happen. The goal is to learn the best ways to u…
Sponsor: Minneapolis Heart Institute Foundation • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
A new exercise plan aims to get pulmonary embolism survivors back on their feet
Disease control Recruiting nowThis study tests whether a personalized, home-based exercise program can help people who have had a moderate-to-severe pulmonary embolism (a blood clot in the lungs) improve their physical capacity and quality of life. Participants will be randomly assigned to receive the exercis…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Heart stent showdown: which medicated device keeps arteries open best?
Disease control Recruiting nowThis study compares two medicated stents (tiny mesh tubes) used to open blocked heart arteries in people having a heart attack or unstable angina. About 2,100 participants will receive either a sirolimus-eluting stent (ihtDEStiny) or an everolimus-eluting stent (Xience). Research…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can targeted balance training help stroke survivors regain stability?
Disease control Recruiting nowThis study tests whether vestibular-oriented balance training or motor dual-task training, added to standard physiotherapy, better improves balance and reduces fall risk in people who had a stroke at least six months ago. About 50 participants will be randomly assigned to one of …
Phase: NA • Sponsor: Ibadat International University, Islamabad • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a simple pill stabilize blood pressure after spinal cord injury?
Disease control Recruiting nowThis trial compares two blood pressure medications—midodrine and droxidopa—against compression stockings and a placebo to see which best stabilizes blood pressure in people with spinal cord injury. Participants have a traumatic injury between C1 and T6, are at least a year post-i…
Phase: PHASE4 • Sponsor: James J. Peters Veterans Affairs Medical Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
CT scans could make heart stent surgery safer and faster
Disease control Recruiting nowThis study tests whether using a CT scan to guide heart stent placement is better than the current standard (IVUS ultrasound) for people with hardened, calcified coronary arteries. About 700 adults with evidence of reduced blood flow to the heart will be randomly assigned to one …
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New pill hopes to ease breathing in rare lung conditions
Disease control Recruiting nowThis study tests an experimental oral drug called ROC-101 in 40 adults with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (ILD-PH). Participants take the drug alongside their standard care for 24 weeks, with a long-term follow…
Phase: PHASE2 • Sponsor: AllRock Bio, Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New device zaps kidney nerves to tame stubborn high blood pressure
Disease control Recruiting nowThis early study tests a new device called HyperQure that uses a keyhole surgery to disable certain nerves around the kidneys. The goal is to help people with resistant hypertension—high blood pressure that stays high despite taking three or more medications. The study will enrol…
Phase: NA • Sponsor: DeepQure Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can cholesterol drugs shield the heart during melanoma immunotherapy?
Disease control Recruiting nowThis study investigates whether aggressive lipid-lowering therapy can reduce plaque buildup in the heart arteries of melanoma patients starting immune checkpoint inhibitors (ICIs). Participants with plaque detected on a heart CT scan are randomly assigned to either usual care or …
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could training one limb at a time boost heart health better than both?
Disease control Recruiting nowThis study tests whether doing strength exercises one limb at a time (unilateral) or both limbs together (bilateral) makes a bigger difference in heart rate variability, muscle strength, and daily function for adults with high blood pressure. Adults aged 40-75 with hypertension w…
Phase: NA • Sponsor: Hacettepe University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug targets hidden heart risk in people with high lp(a)
Disease control Recruiting nowThis study tests a drug called lepodisiran in 252 adults with high levels of Lp(a), a protein linked to heart disease. Participants must have heart disease or be at risk for a first heart event. The drug is given as an injection and compared to a placebo to see if it reduces plaq…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New pill combo aims to shield hearts in diabetes patients
Disease control Recruiting nowThis large phase 3 trial is testing whether adding vicadrostat to the existing drug empagliflozin can reduce the risk of heart problems in adults with type 2 diabetes, high blood pressure, and heart disease. About 11,800 participants will take either the combination or a placebo …
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New pill aims to cut heart attacks in people with 'Hidden' cholesterol risk
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called muvalaplin in over 10,000 adults with high levels of lipoprotein(a), a genetic risk factor for heart disease and stroke. Participants either have had a prior cardiovascular event or are at high risk for a first one. The study measures …
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New device aims to save legs from clot emergencies
Disease control Recruiting nowThis study is testing a device called the Indigo Aspiration System to remove blood clots from leg arteries in people with acute limb ischemia, a condition where a clot suddenly blocks blood flow. About 300 participants will undergo a procedure where the device sucks out the clot.…
Sponsor: Penumbra Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New device aims to clear leg artery clots without major surgery
Disease control Recruiting nowThis study tests a device called the Artix Thrombectomy System to remove blood clots from leg arteries in people with sudden blockages. About 250 adults with symptoms lasting up to 14 days will be enrolled. The goal is to see if the device can safely restore blood flow and preven…
Phase: NA • Sponsor: Inari Medical • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a tiny device suction out dangerous blood clots?
Disease control Recruiting nowThis trial is testing a device designed to remove blood clots from the deep veins of the legs, a condition called deep vein thrombosis (DVT). The study will enroll about 167 adults with acute or subacute DVT to see if the device can safely and effectively clear the blockage. Part…
Phase: NA • Sponsor: BrosMed Medical Co., Ltd • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New stroke device aims to clear clots faster and safer
Disease control Recruiting nowThis study tests a new device and technique (ADAPT 2.0) for removing blood clots in people having an acute ischemic stroke. The goal is to see if it can restore blood flow more completely and safely than current methods. About 750 adults who are already scheduled for clot removal…
Sponsor: Imperative Care, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug duo aims to slash heart disease risk by targeting hidden cholesterol
Disease control Recruiting nowThis study tests whether adding pelacarsen to inclisiran can further lower a type of cholesterol called Lp(a) in people with heart disease. About 340 adults with high Lp(a) and LDL-C will receive either pelacarsen or a placebo, plus inclisiran. The main goal is to see if Lp(a) le…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New hope for heart patients with brain bleed history: catheter ablation vs. standard care
Disease control Recruiting nowThis study compares catheter ablation (a procedure to fix irregular heartbeats) with standard medical care in 646 adults who have both atrial fibrillation and a recent brain bleed. The goal is to see if ablation reduces the risk of death, stroke, or blood clots. Participants must…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New stroke drug enters early safety testing
Disease control Recruiting nowThis early-stage study tests whether a drug called anisodine hydrobromide is safe for people having a stroke caused by a blocked large artery in the brain. About 92 adults aged 18 to 80 who are already scheduled for a clot-removal procedure will receive the drug. The main goal is…
Phase: PHASE1 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could skipping the breathing tube speed heart surgery recovery?
Disease control Recruiting nowThis trial tests whether using a supraglottic airway (a mask-like device) instead of a breathing tube during heart surgery can reduce lung complications and speed recovery. Adults having elective heart valve surgery or bypass will be randomly assigned to either the nonintubated a…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a common diabetes drug help delay preterm birth in preeclampsia?
Disease control Recruiting nowThis phase 3 trial tests whether metformin, a diabetes drug, can safely prolong pregnancy in women with preterm preeclampsia. Currently, the only treatment is early delivery, which risks the baby's health. The study will enroll 294 women across Nordic countries, giving them metfo…
Phase: PHASE3 • Sponsor: Lina Bergman • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can community hospitals in zambia master severe disease care?
Disease control Recruiting nowThis trial tests a new model of care called PEN-Plus, which brings specialized treatment for severe chronic diseases like diabetes, heart conditions, and sickle cell disease to first-level hospitals in Zambia. The goal is to train local health workers and set up clinics to manage…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug cocktail takes on rare adrenal cancer
Disease control Recruiting nowThis phase II trial tests whether adding the immunotherapy cemiplimab to the targeted drug cabozantinib works better than cabozantinib alone for advanced adrenocortical cancer. About 48 adolescents and adults whose cancer has spread or cannot be removed will take part. The study …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New hope for bleeding stroke: can clevidipine save brains?
Disease control Recruiting nowThis study tests whether the drug clevidipine can lower blood pressure quickly and steadily in people having a bleeding stroke (intracerebral hemorrhage). High blood pressure can make the bleeding worse, so getting it under control fast is critical. The trial will compare clevidi…
Sponsor: Zeenat Qureshi Stroke Institute • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a double-barrel cholesterol drug shrink artery plaque better than statins alone?
Disease control Recruiting nowThis study compares two approaches for people with mild-to-moderate carotid artery stenosis (narrowing of the neck arteries): a standard statin regimen versus a statin plus a PCSK9 inhibitor (evolocumab) given as biweekly injections. The main goal is to see whether the combinatio…
Sponsor: Changhai Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Immune cell therapy takes on autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment called NKX019 for people with autoimmune diseases like systemic sclerosis, rheumatoid arthritis, and vasculitis. NKX019 uses specially engineered immune cells to target and calm overactive B cells that cause the disease. The goal is to see if it i…
Phase: PHASE1, PHASE2 • Sponsor: Nkarta, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug aims to shield heart and kidneys from major events
Disease control Recruiting nowThis study tests a daily pill called orforglipron to see if it can prevent major heart problems (like heart attacks or strokes) and slow kidney disease in people who already have heart or kidney disease. About 7,140 adults will take either the drug or a placebo for up to 5 years.…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for AF patients: device may replace blood thinners after brain bleed
Disease control Recruiting nowThis study tests whether closing a small pouch in the heart (the left atrial appendage) with a device is safer and as effective as long-term blood thinners for people with atrial fibrillation who have already had a brain bleed. About 530 participants will be randomly assigned to …
Phase: NA • Sponsor: Jena University Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can removing clots from tiny brain arteries boost stroke recovery?
Disease control Recruiting nowThis study looks at two ways to treat a type of stroke caused by a blockage in a smaller branch of a brain artery. One group receives a procedure to remove the clot (thrombectomy) plus standard medical care, while the other group receives medical care alone. The goal is to see if…
Sponsor: Penumbra Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a Lab-Made protein help fight HIV-Related cancer?
Disease control Recruiting nowThis study tests a lab-made human protein called CYT107 in 55 people with HIV and Kaposi sarcoma. The protein aims to boost T cells, which may help shrink cancer tumors. Participants receive weekly injections for up to 4 weeks, with follow-up for 3 years.
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug aims to stop swelling attacks in hereditary angioedema
Disease control Recruiting nowThis phase 3 study tests an intravenous C1 esterase inhibitor (C1-INH) in people with hereditary angioedema (HAE) to treat acute attacks and prevent attacks before medical procedures. About 124 participants, aged 2 and older, will receive either the drug or a placebo. The main go…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a daily pill replace eye injections for diabetic macular edema?
Disease control Recruiting nowThis study tests an oral medication called BI 1815368 in 300 adults with center-involved diabetic macular edema, a common cause of vision loss in diabetes. Participants take tablets twice daily for about 11 months, and doctors compare vision changes between those on the drug and …
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for cancer patients: experimental drug aims to stop dangerous blood clots
Disease control Recruiting nowThis study tests an experimental drug, REGN7508, to see if it works better than the standard blood thinner apixaban for treating and preventing blood clots in people with cancer. The trial will include about 1,600 participants with or without cancer who have deep vein thrombosis …
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Experimental liquid drug tested in ventilator patients with rare lung bleeding disease
Disease control Recruiting nowThis early study tests whether a liquid form of the drug avacopan can be safely given through a feeding tube to critically ill patients with ANCA vasculitis who have severe lung bleeding and need a ventilator. The main goal is to measure how the drug levels change in the blood ov…
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a pill shield the brain and kidneys during heart surgery?
Disease control Recruiting nowThis trial tests whether vericiguat, a drug that relaxes blood vessels, can protect the body during heart surgery. About 170 adults scheduled for open-heart surgery will receive either vericiguat or a placebo starting two days before the operation. Researchers will measure blood …
Phase: PHASE4 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New stent aims to cut bleeding risk for heart patients on blood thinners
Disease control Recruiting nowThis study tests a new type of stent (a small mesh tube) for people with heart disease who also take blood thinners. These patients have a high risk of bleeding when they also need anti-clotting drugs after stent placement. The new stent is designed to allow a shorter course of a…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New study tests enalapril to shield new moms' hearts after preeclampsia
Disease control Recruiting nowThis study looks at whether giving enalapril, a standard blood pressure medicine, to women who had preeclampsia during pregnancy can help control their blood pressure after childbirth. Researchers will enroll 60 postpartum women and randomly assign them to enalapril or usual care…
Phase: PHASE3 • Sponsor: Women and Infants Hospital of Rhode Island • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Heart artery showdown: balloon or stent for big vessels?
Disease control Recruiting nowThis study looks at two ways to treat blocked large heart arteries (≥3.5 mm) in people with coronary artery disease. One method uses a drug-coated balloon, the other a drug-releasing stent. The goal is to see which helps the artery relax and function better 8 months after treatme…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
One-Stop shop: new study tests dual procedure for AFib patients
Disease control Recruiting nowThis study is testing whether it is safe and effective to perform two heart procedures at the same time in people with atrial fibrillation (AF). The first procedure uses pulsed field ablation to correct the heart's rhythm, and the second closes off a small pouch in the heart to r…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Oxygen straight to the gut: new hope for bowel disease?
Disease control Recruiting nowThis study tests if delivering oxygen directly into the gut through a thin tube can help people with ischemic-hypoxic bowel disease, a condition where the bowel doesn't get enough oxygen. About 90 adults with symptoms like belly pain, bloating, and trouble pooping will receive ei…
Phase: NA • Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can an Oxygen-Boosting drug help when all else fails?
Disease control AVAILABLEThis program allows doctors to request NanO₂, an investigational drug that may help deliver oxygen to tissues, for patients with serious or life-threatening conditions like glioblastoma, respiratory distress, or ischemic stroke. It is for patients who have exhausted other treatme…
Sponsor: NuvOx LLC • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New heart valve registry aims to confirm Real-World success
Disease control Recruiting nowThis study will track 100 people with severe aortic stenosis who receive the Hydra THV heart valve through a less invasive procedure (TAVR). The goal is to see how well the valve works and how safe it is in everyday practice. Participants will be followed for short- and mid-term …
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a new injection tame hereditary swelling attacks?
Disease control AVAILABLEThis program provides access to an investigational drug called donidalorsen for people with hereditary angioedema (HAE), a genetic condition that causes sudden, painful swelling in various body parts. The drug is given as a monthly or every-other-month injection under the skin. I…
Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New antibody drug aims to ease lung blood pressure
Disease control Recruiting nowThis study tests an experimental drug called REGN13335 in 99 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes the heart work harder. Participants will receive either the drug or a placebo, on top of their usual PAH medica…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a tiny mesh device defuse brain aneurysms? a registry investigates
Disease control Recruiting nowThis study is a registry that will follow about 200 people with brain aneurysms who are treated with a flow diverter device (p64, p64 MW, or p48 MW). The goal is to see how safe and effective these devices are in real-world practice across France. Participants will be monitored f…
Sponsor: Phenox GmbH • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New hope for kids with rare swelling disorder as drug trial begins
Disease control Recruiting nowThis study tests a drug called donidalorsen in 20 children aged 2 to 12 with hereditary angioedema (HAE), a condition that causes sudden, painful swelling. The goal is to see if the drug is safe and how it works in young bodies. Researchers will monitor side effects and measure h…
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New blood thinners aim to cut stroke risk with fewer bleeding side effects
Disease control Recruiting nowThis study tests two experimental drugs, REGN7508 and REGN9933, in about 1,200 people with atrial fibrillation (an irregular heartbeat). The goal is to see if these drugs can prevent blood clots and strokes with less bleeding compared to the standard blood thinner apixaban. Parti…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
When to thin the blood after a stroke? new trial seeks answer
Disease control Recruiting nowThis study looks at the best time to start blood thinners in people with atrial fibrillation who had a stroke and emergency treatment to open a blocked artery. About 438 participants will be randomly assigned to start blood thinners within 4 days or between 5-14 days after the st…
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Cord blood hope: new infusion option for kids with brain damage
Disease control AVAILABLEThis program gives children with brain disorders like cerebral palsy or stroke access to umbilical cord blood infusions. The treatment uses donated cord blood cells to help repair brain damage. Kids up to age 26 with normal immune function may qualify. The goal is to improve symp…
Sponsor: Joanne Kurtzberg, MD • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a tiny dose of norepinephrine prevent organ damage during emergency surgery?
Disease control Recruiting nowThis trial tests whether a 5-microgram or 10-microgram bolus of norepinephrine is better at quickly raising dangerously low blood pressure during emergency abdominal surgery. Low blood pressure after anesthesia is common in these surgeries and can harm organs if not treated fast.…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New antibody drugs aim to prevent deadly clots in PAD patients after leg surgery
Disease control Recruiting nowThis phase 3 trial is testing two experimental drugs, REGN7508 and REGN9933, to prevent serious blood clots in people with peripheral artery disease who recently had leg surgery to improve blood flow. The study will enroll about 7,050 participants and compare the drugs to a place…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Brain stimulation plus exercise may lift depression and boost walking after stroke
Disease control Recruiting nowThis trial investigates whether combining repetitive transcranial magnetic stimulation (rTMS) with aerobic exercise can treat depression and improve walking in people who have had a stroke. Participants will receive either real or sham rTMS along with exercise sessions over 12 we…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Balloon vs stent: which works best for Rock-Hard heart plaques?
Disease control Recruiting nowThis study tests two ways to treat hardened calcium deposits in heart arteries. After using sound waves to break up the calcium, doctors will either place a drug-coated balloon or a drug-coated stent. The trial will follow 128 patients for 9 months to see which approach keeps art…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New hope for stroke patients: could a pill combo replace the needle?
Disease control Recruiting nowThis study compares two treatments for small ischemic strokes (lacunar strokes): a combination of antiplatelet drugs (pills) versus the standard clot-busting drug tPA given through an IV. The goal is to see if the pill combo works just as well but causes fewer bleeding problems. …
Phase: PHASE4 • Sponsor: Nippon Medical School • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New eye drug could mean fewer shots for Diabetes-Related vision loss
Disease control Recruiting nowThis study tests a new medicine, EYP-1901, given as an eye injection to people with diabetic macular edema (DME), a condition that causes blurry vision in people with diabetes. The goal is to see if EYP-1901 works as well as the standard treatment (aflibercept) but with fewer inj…
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug YN001 aims to shrink artery plaque in heart disease trial
Disease control Recruiting nowThis study tests a drug called YN001 in 456 adults with coronary atherosclerosis (plaque buildup in heart arteries). Participants receive weekly injections of YN001 or a placebo for 13 weeks. The main goal is to see if YN001 reduces plaque volume in the arteries, as measured by a…
Phase: PHASE2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New eye drug could cut injection frequency for Diabetes-Related vision loss
Disease control Recruiting nowThis phase 3 trial tests EYP-1901, a new eye injection, against the standard treatment aflibercept for diabetic macular edema (DME), a condition that causes vision loss in people with diabetes. The study will enroll 240 participants and compare how well each drug improves vision …
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can Clot-Busters overcome blood thinners to save brains?
Disease control Recruiting nowThis trial investigates whether giving clot-busting drugs (tenecteplase or alteplase) to people who have an ischemic stroke while taking direct oral anticoagulants (blood thinners) is safe and effective. About 906 adults who had a stroke within 48 hours of taking a DOAC will be r…
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Shockwave therapy could crack tough heart blockages
Disease control Recruiting nowThis study tests a new device that uses sound waves to break up calcium deposits in heart arteries before placing a stent. About 408 adults with coronary artery disease will receive this treatment. The goal is to see if the device is safe and effective at clearing blockages to im…
Phase: NA • Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New clip device tested for leaky heart valve fix
Disease control Recruiting nowThis study is checking how safe and well a device called TriClip works for people with a leaky heart valve (tricuspid regurgitation). The device is already approved for use, and this study will watch 1000 adults who get it to see how they do. The goal is to make sure the device w…
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug cocktail aims to boost stroke recovery in mild cases
Disease control Recruiting nowThis study tests whether adding butylphthalide (a neuroprotective drug) to standard clot-busting tenecteplase helps people with mild but disabling stroke recover better. About 1,062 adults aged 18-80 who can be treated within 4.5 hours of symptoms will receive either the combo or…
Phase: PHASE3 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a fitness app boost recovery after heart valve replacement?
Disease control Recruiting nowThis trial tests whether an eight-week digital cardiac rehabilitation program using the Peloton app can improve physical activity and recovery in people who have had a transcatheter aortic valve replacement (TAVR). Participants are randomly assigned to either the digital rehab pr…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Which pill combo tames Post-Birth hypertension best?
Disease control Recruiting nowThis study tests whether a combination of nifedipine and enalapril controls high blood pressure after childbirth better than nifedipine and labetalol. It involves 200 postpartum women with persistent hypertension. The goal is to reduce hospital stays, readmissions, and severe blo…
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Inhaled sirolimus trial aims to ease breathing in lung scar patients
Disease control Recruiting nowThis Phase 2 trial tests an inhaled drug called LAM-001 (sirolimus) in 85 adults who have pulmonary hypertension (high blood pressure in the lungs) along with interstitial lung disease (lung scarring). The study compares the drug to a placebo to see if it improves blood flow in t…
Phase: PHASE2 • Sponsor: OrphAI Therapeutics • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a Cholesterol-Lowering drug stop brain arteries from narrowing further?
Disease control Recruiting nowThis study tests whether pemafibrate, a drug that lowers triglycerides, can prevent the worsening of narrowed brain arteries in people who have already had a stroke or mini-stroke. About 270 participants will be randomly assigned to receive either pemafibrate plus standard care o…
Phase: NA • Sponsor: Tokyo Women's Medical University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Brain-Powered rehab: robot reads mind and muscles to restore hand movement after stroke
Disease control Recruiting nowThis trial tests whether a wrist-hand rehabilitation robot that uses both brain and muscle signals can help people with chronic stroke recover better than one using muscle signals alone. Forty-eight participants will receive 20 training sessions with the robot, which provides ele…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New study targets rare Virus-Driven inflammatory syndrome
Disease control Recruiting nowThis study looks at a newly recognized disease called KSHV Inflammatory Cytokine Syndrome (KICS), caused by a virus that can also lead to certain cancers. Researchers aim to learn more about the disease and test experimental treatments, including antiviral and chemotherapy drugs,…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New antibody aims to tame rare bleeding disorder
Disease control Recruiting nowThis early-phase trial tests an experimental antibody called DIAG723 in 93 adults with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels and frequent nosebleeds. The study will check if the drug is safe and how the body processes it, with…
Phase: PHASE1, PHASE2 • Sponsor: Diagonal Therapeutics, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a new catheter make heart stenting safer and more effective?
Disease control Recruiting nowThis trial is testing a new coronary extension catheter designed to help doctors deliver balloons and stents more easily during percutaneous coronary intervention (PCI) for coronary artery disease. The study will enroll about 69 adults who need PCI and for whom the catheter is pl…
Phase: NA • Sponsor: BrosMed Medical Co., Ltd • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
The eyes may hold a window to brain health: a trial tests a new marker and treatment
Disease control Recruiting nowThis study investigates whether changes in retinal blood vessels can serve as a marker for cerebral small vessel disease (SVD), a common condition in older adults that increases stroke and dementia risk. The trial includes people with SVD-related conditions like CADASIL, sporadic…
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New hope for rare childhood cancer: drug cocktail aims to shrink tumors and prevent return
Disease control Recruiting nowThis study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. It tests whether adding the drugs pazopanib and selinexor to standard chemotherapy can improve outcomes. Participants receive treatment tailored to their…
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a cheap vitamin shield the aging brain during heart surgery?
Disease control Recruiting nowThis study tests whether giving thiamine (vitamin B1) during coronary artery bypass surgery can reduce the memory and thinking problems that sometimes follow the procedure. Older adults with coronary heart disease who are scheduled for bypass surgery and have low thiamine levels …
Phase: EARLY_PHASE1 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Gene-Editing shot could slash cholesterol for good
Disease control Recruiting nowThis early-stage trial tests a single IV dose of VERVE-102, a gene-editing drug designed to permanently lower LDL (bad) cholesterol by turning off a specific gene in the liver. It involves 85 adults with inherited high cholesterol or early heart disease who still need lower chole…
Phase: PHASE1 • Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Experimental CAR-T therapy takes on lupus and more
Disease control Recruiting nowThis early-stage study tests a new treatment called RD06-05, a universal CAR-T cell therapy, in up to 84 adults with autoimmune diseases like lupus, vasculitis, and scleroderma. The therapy targets and removes faulty immune cells to help control the disease. The main goal is to c…
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could water pills be the key to protecting kidneys and hearts?
Disease control Recruiting nowThis phase 3 trial is testing whether a blood pressure treatment plan that focuses on diuretics (water pills) works better than usual care for people with moderate to severe chronic kidney disease and uncontrolled high blood pressure. The study will include 720 participants and t…
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Wall squats at home could be the new way to lower blood pressure
Disease control Recruiting nowThis study tests whether doing wall squats at home, along with lifestyle advice, is a practical and acceptable way for people with high blood pressure to manage their condition. Seventy adults with hypertension will do supervised wall squat exercises three times a week for 12 wee…
Phase: NA • Sponsor: Northumbria University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Which therapy restores walking after stroke? a Head-to-Head test
Disease control Recruiting nowThis trial compares two rehabilitation approaches—neurodevelopmental technique (NDT) and mirror therapy—to see which better improves coordination, leg function, and walking ability in people recovering from a sub-acute stroke. Forty adults aged 45 to 65 with hemiplegia (weakness …
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Sound waves to zap hypertension? new trial tests ultrasound treatment
Disease control Recruiting nowThis study tests a device that uses ultrasound to calm overactive nerves in the kidneys, which can drive high blood pressure. About 261 adults with hypertension will either get the real procedure or a sham (fake) one. The goal is to see if this approach safely lowers blood pressu…
Phase: NA • Sponsor: SoniVie Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
A digital coach for the heart: app aims to keep risk factors in check after a heart attack
Disease control Recruiting nowThis trial tests whether a smartphone app called HeartCheck can help people who have recently survived a heart attack better manage their blood pressure, cholesterol, blood sugar, and smoking habits. The app provides education, reminders, and easy-to-understand goals to support m…
Phase: NA • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a vitamin d boost strengthen bones and mobility after neurological injury?
Disease control Recruiting nowThis trial is testing whether vitamin D supplements can improve bone density, body composition, strength, walking speed, and physical performance in people hospitalized with neurological disorders like stroke, spinal cord injury, or traumatic brain injury. Participants will recei…
Phase: NA • Sponsor: Dionyssiotis, Yannis, M.D. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Electrical implant aims to restore movement after paralysis
Disease control Recruiting nowThis study tests an implanted electrical stimulation device designed to improve movement, standing, and walking in people with paralysis from spinal cord injury, stroke, multiple sclerosis, or traumatic brain injury. The device sends electrical signals to muscles in the trunk and…
Phase: NA • Sponsor: Louis Stokes VA Medical Center • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Butcher's broom extract put to the test for vein health
Disease control Recruiting nowThis study follows over 500 people with chronic venous disease who are taking Ruscus aculeatus L., a plant extract also known as butcher's broom, as part of their routine care. Researchers will track changes in vein-related symptoms, pain, and quality of life over 90 days. The go…
Sponsor: Turkish Society for Vascular and Endovascular Surgery • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could an old arthritis pill keep brain arteries open and prevent stroke?
Disease control Recruiting nowThis trial tests whether low-dose colchicine, an anti-inflammatory drug typically used for gout, can reduce stroke risk and artery plaque in people with intracranial atherosclerotic disease (ICAD). ICAD is a leading cause of stroke in Asia, and even with standard treatment, the r…
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Which PAH treatment strategy works better: adding a third drug or increasing the dose?
Disease control Recruiting nowThis study compares two ways to intensify treatment for people with pulmonary arterial hypertension (PAH) who are not doing well enough on standard dual therapy. One group adds a third type of medication (a prostacyclin pathway agent), while the other group increases the dose of …
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can blood thinners be safer for stroke patients with hidden brain bleeds?
Disease control Recruiting nowThis study follows 3,000 ischemic stroke patients who also have cerebral microbleeds — tiny spots of old blood in the brain. Researchers are tracking how different antithrombotic drugs (blood thinners) affect the number of microbleeds and the risk of future strokes or brain bleed…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a lower dose of an eye drug protect preterm Infants' sight?
Disease control Recruiting nowThis trial investigates whether a low dose of the drug conbercept can effectively treat retinopathy of prematurity (ROP), an eye disease that can cause blindness in preterm infants. The study will enroll 146 preterm babies with type 1 ROP and compare the low-dose treatment agains…
Phase: NA • Sponsor: Wang Yusheng • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could a single eye implant replace years of glaucoma drops?
Disease control Recruiting nowThis trial tests a new implant that slowly releases the glaucoma drug timolol inside the eye. It is for people with open-angle glaucoma or ocular hypertension who are already having cataract surgery. The study compares three doses of the implant against standard timolol eye drops…
Phase: PHASE1, PHASE2 • Sponsor: EyeD Pharma • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Community health workers take on hypertension: a culturally grounded trial
Disease control Recruiting nowThis trial tests whether a community health worker-led education program, called Heart Health and Nutrition for Life (HHNL), can help people with high blood pressure lower their numbers. The program covers healthy eating, physical activity, medication adherence, stress reduction,…
Phase: NA • Sponsor: University of New Mexico • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Which heart stent works best? a large registry aims to find out
Disease control Recruiting nowThis registry tracks 5,000 people with coronary artery disease who receive one of three drug-eluting stents during angioplasty: Biolimus, Everolimus, or Zotarolimus. Researchers will compare rates of heart-related death, heart attack, and repeat procedures over two years. The goa…
Sponsor: Yonsei University • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
A simple gas flush before aortic repair might prevent strokes
Disease control Recruiting nowThis trial tests whether flushing a stent-graft with carbon dioxide before implanting it in the aorta can reduce the number of tiny air bubbles that travel to the brain during the procedure. These bubbles are a major cause of stroke and silent brain damage in patients undergoing …
Phase: NA • Sponsor: University of Bologna • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Wall squats tested as a blood pressure hack for sleep apnea patients
Disease control Recruiting nowThis study tests whether a simple isometric wall squat exercise can lower blood pressure in adults with both hypertension and obstructive sleep apnea treated with CPAP. Each participant will complete one session of wall squats and one rest-only session, with blood pressure monito…
Phase: NA • Sponsor: Aveiro University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Brain wave battle: deeper suppression may halt post-arrest seizures
Disease control Recruiting nowAfter a cardiac arrest, some patients develop seizures that do not respond to standard treatment. This trial tests whether putting the brain into a deeper state of electrical silence — called burst suppression — can stop those seizures better than the usual approach of only suppr…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a single antiplatelet drug beat aspirin after heart valve replacement?
Disease control Recruiting nowThis trial compares two single antiplatelet therapies—ticagrelor versus aspirin—in people who have just undergone transcatheter aortic valve implantation (TAVI) for severe aortic stenosis. The goal is to see which drug better prevents serious complications like stroke, heart atta…
Phase: PHASE4 • Sponsor: Fundacin Biomedica Galicia Sur • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
A simple arm cuff may lower blood pressure without drugs
Disease control Recruiting nowThis trial tests whether a device called remote ischemic conditioning can safely help lower blood pressure in people with essential hypertension. The treatment involves inflating a blood pressure cuff on the upper arm to briefly stop blood flow, then releasing it, in repeated cyc…
Phase: NA • Sponsor: Yi Yang • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Stem cell 'secretome' may reboot the brain after stroke — a trial puts it to the test
Disease control Recruiting nowThis pilot trial tests whether a substance made from stem cells — called mesenchymal stem cell secretome — can improve cognitive recovery in people who have had an ischemic stroke. Participants aged 40 to 75 with mild-to-moderate cognitive impairment will receive either standard …
Phase: NA • Sponsor: Jumraini Tammasse • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
A diet designed for puerto rico: can traditional foods fight heart disease and diabetes?
Disease control Recruiting nowThis trial tests whether a diet adapted to Puerto Rican culture can lower the risk of heart disease, type 2 diabetes, and obesity. Researchers will compare culturally tailored nutrition advice—emphasizing traditional healthy foods and limiting unhealthy ones—with standard healthy…
Phase: NA • Sponsor: Harvard School of Public Health (HSPH) • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a new antiplatelet drug outperform clopidogrel after a heart attack?
Disease control Recruiting nowThis phase III trial tests whether vicagrel, an experimental antiplatelet drug, can prevent major heart-related events better than the standard drug clopidogrel in people with acute coronary syndrome (such as a heart attack or unstable angina) who are undergoing a stent procedure…
Phase: PHASE3 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Beetroot juice and exercise: a new hope for leg pain from clogged arteries?
Disease control Recruiting nowThis trial tests whether a 12-week supervised treadmill exercise program can improve blood flow and walking distance in people with peripheral artery disease (PAD). It also explores whether adding nitrate-rich beetroot juice helps those who don't respond to exercise alone. Two hu…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a faster, Higher-Power heart ablation beat the standard for AFib?
Disease control Recruiting nowThis trial tests whether a new high-power short-duration radiofrequency ablation technique (90 watts for 4 seconds) is safer and more effective than the standard low-power approach (35 watts for 10-15 seconds) for treating atrial fibrillation. The study includes adults with parox…
Phase: NA • Sponsor: Bakulev Scientific Center of Cardiovascular Surgery • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a metronome beat retrain the brain after a stroke?
Disease control Recruiting nowThis trial tests whether adding rhythmic auditory stimulation (like a metronome) to task-oriented training improves lower limb function, balance, and motivation in people recovering from a stroke. Participants, aged 40 to 60 with a first-time stroke within the past six months, wi…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Squeeze away hypertension? handgrip device put to the test
Disease control Recruiting nowThis trial tests whether using a handgrip device for isometric exercise can lower blood pressure in people with elevated blood pressure or hypertension who are not on medication. Half the participants will use the Zona Plus handgrip device, while the other half will listen to rel…
Phase: NA • Sponsor: Zona Health, Inc • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
AI tailors lifestyle tips to tackle high blood pressure
Disease control Recruiting nowThis trial tests whether a digital health tool that uses artificial intelligence can help people with high blood pressure lower their numbers. The AI analyzes daily habits and blood pressure readings to give each person personalized lifestyle suggestions. Researchers will compare…
Phase: NA • Sponsor: National Bureau of Economic Research, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can juggling two tasks at once help stroke survivors walk better?
Disease control Recruiting nowThis trial tests whether practicing walking while doing a second task — like talking or carrying something — improves balance and reduces fall risk more than simply repeating walking exercises. The study enrolls adults aged 40 to 70 who had a stroke 6 months to 1 year ago and sti…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Slow breaths, faster recovery? a trial tests breathing and neck release after stroke
Disease control Recruiting nowThis trial investigates whether adding deep, slow breathing exercises and a gentle neck-release technique to standard physical therapy can improve heart rate control, movement, thinking, and mood in people who have had a stroke. The study includes 54 adults who had a first stroke…
Phase: NA • Sponsor: Ankara Yildirim Beyazıt University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Pre-surgery exercise program may help high-risk heart patients leave the hospital sooner
Disease control Recruiting nowThis trial tests whether a structured physiotherapy program started at least two days before coronary artery bypass grafting (CABG) and continued after surgery can improve recovery in high-risk patients. Participants are adults scheduled for elective CABG who meet at least three …
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Robots vs. therapists: a head-to-head trial for stroke recovery
Disease control Recruiting nowThis large trial compares robot-assisted rehabilitation to traditional one-on-one physiotherapy for people who have had a stroke. Researchers are measuring how well each approach helps patients regain independence in daily activities, as well as costs and patient satisfaction. Th…
Phase: NA • Sponsor: Fondazione Don Carlo Gnocchi ETS • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Stroke recovery from home: can video-based motor training outperform standard physical therapy?
Disease control Recruiting nowThis study compares two types of telerehabilitation for stroke survivors: a motor relearning program that focuses on retraining specific tasks versus conventional physical therapy delivered remotely. Researchers will measure changes in motor function and balance in adults aged 40…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Which works better: electric needle or foam injection for troubled leg veins?
Disease control Recruiting nowThis trial compares two minimally invasive procedures for treating incompetent perforating veins—veins that fail to close properly and can cause leg swelling, skin changes, or ulcers. One method uses a needle to deliver an electric current to seal the vein, while the other inject…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Which arm therapy helps stroke survivors regain motor skills faster?
Disease control Recruiting nowThis trial compares two rehabilitation approaches — task-oriented training and hand-arm bimanual intensive therapy — in stroke survivors with mild to moderate arm weakness. The goal is to see which method better improves gross and fine motor skills and the ability to perform dail…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
A new Catheter-Based valve could fix a leaky heart valve without surgery
Disease control Recruiting nowThis trial tests a new device, the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System, designed to replace the tricuspid valve in people with severe, symptomatic tricuspid regurgitation. The procedure is done through a catheter, avoiding open-heart surgery. The study…
Phase: NA • Sponsor: Laplace Interventional, Inc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Placental clues from a past pregnancy may guide treatment to prevent future complications
Disease control Recruiting nowThis pilot trial tests whether using placental tissue analysis from a prior complicated pregnancy can guide treatment with the blood thinner enoxaparin to reduce the risk of recurrent adverse outcomes. The study enrolls women who had a previous pregnancy affected by early deliver…
Phase: PHASE2 • Sponsor: Endeavor Health • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Metaverse meets microsurgery: XR platform aims to sharpen brain bypass precision
Disease control Recruiting nowThis study tests a metaverse-based surgical platform that uses extended reality (XR) to help surgeons precisely locate blood vessels during brain bypass surgery. The trial includes 30 adults with moyamoya disease or chronic cerebral ischemia who need an extracranial-intracranial …
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a diabetes drug help the lungs? pioglitazone put to the test for pulmonary hypertension
Disease control Recruiting nowThis phase 2 trial tests whether pioglitazone, a drug used for diabetes, can improve how cells use oxygen in people with pulmonary hypertension caused by chronic lung disease. Participants take pioglitazone or a placebo daily for 28 days, then switch after a 2-week break. The stu…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Stroke recovery from home: tele-rehab may match clinic therapy for arm function
Disease control Recruiting nowThis trial tests whether a structured arm therapy program delivered through video calls can improve upper limb function in people who had a stroke at least six months ago, compared with the same therapy given in a clinic. Sixty-eight participants will receive modified Constraint-…
Phase: NA • Sponsor: Kainat Tariq • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a No-Fridge migraine shot replace botox?
Disease control Recruiting nowThis phase 3 trial tests whether incobotulinumtoxinA (Xeomin), a botulinum toxin that does not require refrigeration, works as well as onabotulinumtoxinA (Botox) for preventing chronic migraine. Adults with 15 or more headache days per month will receive injections of either drug…
Phase: PHASE3 • Sponsor: Naval Medical Center Camp Lejeune • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a jolt of electricity boost stroke rehab?
Disease control Recruiting nowThis trial tests whether adding electrical muscle stimulation to a standard motor relearning program improves arm function more than the program alone in people recovering from a subacute stroke. Thirty-six participants will receive either the combined therapy or the program only…
Phase: NA • Sponsor: Montiha Azeem • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Brain filter may prevent stroke during heart procedure
Disease control Recruiting nowThis study tests whether a filter device called the Sentinel Cerebral Protection System can prevent stroke and brain injury during ablation for atrial fibrillation (an irregular heartbeat). The device is placed in the arteries to catch debris that might break loose during the pro…
Phase: NA • Sponsor: Malini Madhavan • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Wearable hip robot could bring stroke rehab home
Disease control Recruiting nowThis trial tests whether a hip-assisted wearable robot can help stroke survivors improve their walking through at-home training sessions. Eight adults who have had a stroke and walk with a spastic hemiplegic gait will use the robot during four 30-minute sessions over two weeks, g…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Structured diet coaching may improve control of multiple chronic diseases
Disease control Recruiting nowThis study tests whether a structured nutrition counselling program can improve diet, blood sugar, blood pressure, and quality of life in adults who have both type 2 diabetes and hypertension. About 308 participants from 14 hospitals in Ethiopia will either receive six individual…
Phase: NA • Sponsor: Bahir Dar University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a common cholesterol drug stop chronic migraine?
Disease control Recruiting nowThis study tests whether taking atorvastatin (a widely used cholesterol-lowering drug) every day for 12 weeks can reduce the number of migraine days in people with chronic migraine. About 300 adults aged 18–64 with chronic migraine will receive either atorvastatin or a placebo pi…
Phase: PHASE2 • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Adding strength training to cardiac rehab may boost recovery after bypass surgery
Disease control Recruiting nowThis study tests whether combining aerobic exercise with strength training helps people recover better after coronary artery bypass graft (CABG) surgery. Participants, aged 30 to 60 and cleared for phase II cardiac rehab, are randomly assigned to aerobic exercise alone or aerobic…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Simple hand exercises may slash risk of painful IV complication
Disease control Recruiting nowThis trial tests whether gentle massage and palm-to-fist tapping near an IV insertion site can reduce the risk of phlebitis, a painful inflammation of the vein. Hospitalized adults with a peripheral IV in their arm are randomly assigned to receive standard care or add these simpl…
Phase: NA • Sponsor: Hospital Universitario San Ignacio • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Robots help stroke survivors regain arm and hand movement
Disease control Recruiting nowThis study tests whether a robot can help people who had a stroke 1 to 12 months ago improve movement and feeling in their arm and hand. Participants first receive gentle, robot-guided stretching, then practice active movements with the robot, which can assist or resist as needed…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Cloaked clot-buster: platelet coating may sharpen attack on arterial blockages
Disease control Recruiting nowThis study tests a new version of the clot-dissolving drug tenecteplase, coated with platelet membranes, to see if it targets blood clots more effectively. Researchers will apply the coated drug to blood clots made from samples taken from people with coronary artery disease and h…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a trained eye match ultrasound for heart stent placement?
Disease control Recruiting nowThis trial tests whether an experienced doctor's eye, guided by standard X-ray images, can place a heart stent as well as using a special ultrasound probe inside the artery. The study focuses on the left main coronary artery, a critical vessel. All patients receive the same type …
Phase: NA • Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Heart clot showdown: could a simpler blood thinner replace warfarin?
Disease control Recruiting nowThis trial tests whether apixaban, a newer blood thinner with fixed dosing, works as well as warfarin for dissolving dangerous blood clots in the heart's main pumping chamber. Adults with a confirmed left ventricular thrombus are randomly assigned to receive either apixaban or wa…
Phase: PHASE3 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Eye implant could restore sight after retinal vein blockage
Disease control Recruiting nowThis phase 3 trial tests a single injection of SMO1, a dexamethasone implant placed inside the eye, for people with macular edema (swelling) caused by a blocked retinal vein. The study compares SMO1 to an existing dexamethasone implant to see which better improves vision and redu…
Phase: PHASE3 • Sponsor: SANGMYUNG innovation • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Phone coach after heart attack may slash cholesterol and save lives
Disease control Recruiting nowThis trial tests whether a 'care champion' — a person who calls patients after they leave the hospital following a heart attack or stent procedure — can help them get their LDL cholesterol to a healthy level. Participants also receive education for their doctors. The study compar…
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Brain aneurysm showdown: which procedure is safer?
Disease control Recruiting nowThis trial compares two endovascular procedures for treating unruptured wide-neck brain aneurysms: a flow diverter device (Pipeline) versus traditional stent-assisted coiling. About 266 adults aged 18–75 with these aneurysms will be randomly assigned to one treatment and followed…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a common gout pill protect hearts in HIV?
Disease control Recruiting nowThis trial tests whether colchicine, an anti-inflammatory drug used for gout, can reduce inflammation in the coronary arteries of people with HIV who have high cardiovascular risk. Participants take either colchicine or a placebo daily for 96 weeks, and changes in artery inflamma…
Phase: PHASE2 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Brain artery stent coated with drug may cut stroke risk better than pills alone
Disease control Recruiting nowThis trial compares two strategies to prevent another stroke in people with severe narrowing of a major brain artery. One group receives a drug-eluting stent (a mesh tube that releases medication to keep the artery open) along with aggressive blood-thinning medication. The other …
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
AI health coach aims to lower blood pressure without a clinic visit
Disease control Recruiting nowThis study tests whether an AI-powered digital health platform can help people manage their blood pressure better than support from a human case manager. Adults aged 18 to 75 with high blood pressure use the platform to get reminders, health education, and alerts for abnormal rea…
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
A new brain monitor could reveal stroke outcomes in minutes
Diagnosis Recruiting nowThis study tests whether a bedside monitoring device, placed on the head right after a mechanical thrombectomy for acute ischemic stroke, can predict which patients will have poor neurological outcomes. The device uses near-infrared spectroscopy to measure brain oxygen levels and…
Phase: NA • Sponsor: Beijing Shijitan Hospital, Capital Medical University • Aim: Diagnosis
Last updated Aug 18, 2026 01:00 UTC
-
New scan could spot hidden scarring in heart and lungs before It's too late
Diagnosis Recruiting nowThis study tests a new radioactive tracer called 18F-FAPI-74 that may help detect scar tissue (fibrosis) in the heart and lungs earlier than current methods. Researchers will compare this new PET/CT scan to standard imaging in 210 adults with conditions like lung disease or heart…
Phase: PHASE3 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Diagnosis
Last updated Aug 18, 2026 01:00 UTC
-
New ultrasound technique could replace needle test for liver pressure
Diagnosis Recruiting nowThis study tests whether a special ultrasound technique (SHAPE) can detect high blood pressure in the liver without using a needle. Portal hypertension is a serious condition that can lead to severe liver damage and death. The standard test requires inserting a catheter into a ve…
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
New heart scans aim to slash radiation while boosting accuracy
Diagnosis Recruiting nowThis study is testing new, lower-radiation CT scan methods for taking pictures of the heart and blood vessels. Researchers want to see if these scans are accurate at finding blocked arteries and predicting future heart problems like heart attacks. About 5,000 adults who need a he…
Phase: NA • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Bedside brain scanner could speed up injury detection in kids
Diagnosis Recruiting nowThis study will test a portable, low-field MRI machine to see how well it detects brain injuries from lack of oxygen or blood flow in children. About 200 kids in intensive care will get both a portable and a standard MRI. The goal is to find out if the portable version is accurat…
Phase: NA • Sponsor: Children's Mercy Hospital Kansas City • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
One scan, many answers: can a new CT predict heart risks after stenting?
Diagnosis Recruiting nowThis study is testing whether a new type of CT scan, called photon-counting CT, can do it all in one go for people who have had a coronary stent placed. The scan aims to check the stent and arteries, measure blood flow to the heart muscle, and assess heart function in a single ex…
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Can a new CT scanner see carotid plaques better?
Diagnosis Recruiting nowThis study compares two types of CT scans for imaging the buildup of plaque in the carotid arteries, which supply blood to the brain. The newer photon-counting detector CT (PCD-CTA) will be compared with the standard energy-integrating detector CT (EID-CTA) in 100 people with car…
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
New MRI dye could spot dangerous artery blockages better
Diagnosis Recruiting nowThis Phase 3 trial tests whether a new contrast agent called gadopiclenol works as well as the standard agent (Dotarem) for MRI scans to find blocked arteries in the neck, legs, or abdomen. About 315 adults with suspected vascular disease will receive both agents in random order …
Phase: PHASE3 • Sponsor: Guerbet • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
No more cuff? new patch could track blood pressure all day
Diagnosis Recruiting nowThis study is testing a chest-patch that uses light to measure blood pressure without a traditional arm cuff. Researchers will compare its readings over 24 hours to the standard cuff-based method in 600 adults with or without high blood pressure. The goal is to see if the patch i…
Phase: NA • Sponsor: Biobeat Technologies Ltd. • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Back pain or blocked arteries? new study aims to tell them apart
Diagnosis Recruiting nowThis study will check how common peripheral artery disease (PAD) is in people who need surgery for lumbar spinal stenosis (LSS). Both conditions can cause leg pain, making PAD hard to spot. Researchers will use a special CT scan to find PAD and compare it with simpler tests like …
Phase: NA • Sponsor: Rennes University Hospital • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Could a heart MRI replace invasive scans for some heart attacks?
Diagnosis Recruiting nowThis study explores whether performing a cardiac MRI (CMR) before the standard invasive coronary angiography (ICA) can accurately diagnose the cause of a suspected non-ST-elevation heart attack (NSTEMI). Currently, patients with NSTEMI often undergo an invasive angiogram, and if …
Sponsor: Region Stockholm • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Can a Contrast-Free MRI match ultrasound for spotting Stroke-Causing blockages?
Diagnosis Recruiting nowThis study looks at 200 adults who have had an ischemic stroke or transient ischemic attack (TIA). Each participant will receive two types of imaging: a non-contrast magnetic resonance angiography (NC-MRA) and a carotid Doppler ultrasound. The goal is to see how well these two me…
Sponsor: Sohag University • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
AI eye doctor: could software catch diabetic blindness sooner?
Diagnosis Recruiting nowThis trial evaluates an artificial intelligence system designed to automatically detect signs of diabetic retinopathy in retinal photographs. Researchers will compare the AI's performance against experienced ophthalmologists using a large set of eye images from adults with the co…
Sponsor: Democritus University of Thrace • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
Portable MRI could spot brain injury in children on life support
Diagnosis Recruiting nowThis study tests whether a portable, low-field MRI machine can detect brain injuries in children who are on ECMO (a heart-lung bypass machine). The MRI is brought to the bedside, avoiding the need to move critically ill children. Researchers will scan children at several time poi…
Phase: NA • Sponsor: Children's Mercy Hospital Kansas City • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
Xenon MRI breathes new life into lung disease detection
Diagnosis Recruiting nowThis study explored whether a special type of MRI using inhaled xenon gas could detect changes in the small blood vessels of the lungs in people with pulmonary hypertension. The goal was to see if this imaging method could track disease progression or response to treatment. Howev…
Phase: PHASE2 • Sponsor: Bastiaan Driehuys • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
A new multi-test approach may spot hidden blood vessel damage before symptoms appear
Diagnosis Recruiting nowThis observational study is testing whether a combination of non-invasive measurements—including blood pressure monitoring, ultrasound, blood and urine tests, and a light-based technique called photoplethysmography—can detect early damage to blood vessels and organs in adults at …
Sponsor: Complejo Hospitalario Universitario de Santiago • Aim: Diagnosis
Last updated Aug 07, 2026 00:00 UTC
-
Can a simple electrical scan spot dangerous lung clots without radiation?
Diagnosis Recruiting nowThis study is testing whether a noninvasive imaging technique called pulsatile electrical impedance tomography (EIT) can accurately diagnose acute pulmonary embolism — a life-threatening blood clot in the lungs. Researchers will compare EIT readings with standard CT scans in 275 …
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
AI reads your heartbeat to catch silent killer in lung patients
Diagnosis Recruiting nowThis study tests whether an artificial intelligence (AI) tool that analyzes a simple ECG can help doctors find undiagnosed pulmonary hypertension (high blood pressure in the lungs) in people with interstitial lung disease. About 900 adults with severe lung scarring will be random…
Phase: NA • Sponsor: Tempus AI • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
A new window into Babies' eyes: can advanced imaging improve care for premature infants?
Diagnosis Recruiting nowThis study is testing a new, noninvasive imaging device called HH-SECTR to see inside the eyes of premature infants with retinopathy of prematurity (ROP), a condition that can affect vision. The goal is to see if this technology can provide clearer, more detailed images of the re…
Sponsor: Vanderbilt University Medical Center • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Portable helmet scanner aims to spot brain bleeds in minutes
Diagnosis Recruiting nowThis trial tests a new portable brain scanner designed to quickly detect bleeding in the brain (hemorrhagic stroke) using harmless radio waves. The helmet-like device could offer a faster, more accessible alternative to CT or MRI scans in emergency settings. Researchers will enro…
Sponsor: EMVision Medical Devices Ltd • Aim: Diagnosis
Last updated Jul 29, 2026 00:00 UTC
-
Marathon runners and heart patients put a new troponin test to the ultimate challenge
Diagnosis Recruiting nowThis study tests whether a lab technique called polyethylene glycol (PEG) precipitation can tell the difference between a true heart attack and a harmless condition called macrotroponin, where troponin molecules clump together and falsely signal heart damage. Researchers will com…
Phase: NA • Sponsor: Technical University of Munich • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
AI eye doctor: could a computer spot Blindness-Causing diseases faster than humans?
Diagnosis Recruiting nowThis trial tests whether an artificial intelligence system called VeriSee can help doctors diagnose age-related macular degeneration and diabetic retinopathy from standard eye photos. The AI analyzes the images and provides instant results for the ophthalmologist to consider. Res…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
New imaging algorithm could spot hidden cause of chest pain without invasive procedures
Diagnosis Recruiting nowThis study aims to create a non-invasive diagnostic algorithm using PET imaging and CT scans to identify microvascular angina in patients who have chest pain and signs of ischemia but no blocked coronary arteries. About 70 participants with symptoms of angina or shortness of brea…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
Blood test could predict clot risk after heart valve surgery
Diagnosis Recruiting nowThis study investigates whether a blood test measuring clotting and clot-busting markers can predict complications in patients undergoing aortic valve replacement. Researchers will follow 750 adults with aortic stenosis who receive either surgical or catheter-based valve replacem…
Sponsor: East and North Hertfordshire NHS Trust • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
Progesterone pill may stop dangerous pregnancy condition
Prevention Recruiting nowThis study tests whether taking progesterone early in pregnancy can prevent preeclampsia, a condition that causes high blood pressure and organ damage. Over 600 low-risk pregnant women will either receive nightly vaginal progesterone or standard care. Researchers will track who d…
Phase: PHASE4 • Sponsor: Medical University of South Carolina • Aim: Prevention
Last updated Aug 18, 2026 01:00 UTC
-
New migraine prevention pill EVO756 enters Mid-Stage trial
Prevention Recruiting nowThis Phase 2 study tests whether a daily pill called EVO756 can prevent migraines in adults who have not had success with other preventive treatments. About 330 participants will receive either EVO756 or a placebo, and researchers will track how many migraine days they have each …
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
Online therapy plus pill may cut Kids' migraines in half
Prevention Recruiting nowThis study tests whether adding a daily pill (amitriptyline) to online cognitive behavioral therapy (CBT) helps prevent migraines in children better than online therapy alone. About 400 kids with frequent migraines will be followed for months to see if headache days drop by half …
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
Pilot fish study: bringing HIV prevention to routine clinic visits
Prevention Recruiting nowThis study looks at whether patients and doctors in a family planning clinic find it acceptable to discuss and start PrEP, a daily pill that prevents HIV. About 83 English- or Spanish-speaking patients aged 16 and older, along with their doctors, will take part. Patients will rec…
Phase: NA • Sponsor: Women and Infants Hospital of Rhode Island • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
One pill to shield the heart? a polypill aims to prevent heart failure in diabetes
Prevention Recruiting nowThis trial tests whether a single polypill combining three medications—finerenone, empagliflozin, and losartan—can help prevent heart failure and maintain exercise capacity in people with type 2 diabetes who are at high risk. Participants will take either the polypill or the same…
Phase: PHASE1, PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Aug 06, 2026 00:00 UTC
-
Spud-tacular study: potatoes may ward off diabetes in seniors
Prevention Recruiting nowThis study looks at whether a diet rich in whole white potatoes can improve blood sugar control and blood pressure in adults aged 50-70 who are at risk for type 2 diabetes. Participants will eat either a potato-rich healthy diet or a typical Western diet for 12 weeks. Researchers…
Phase: NA • Sponsor: Virginia Polytechnic Institute and State University • Aim: Prevention
Last updated Aug 06, 2026 00:00 UTC
-
Could a simple aspirin pill replace daily shots to prevent postpartum blood clots?
Prevention Recruiting nowThis trial tests whether taking a low-dose aspirin pill every day for six weeks after delivery can prevent dangerous blood clots in the legs or lungs as effectively as the standard daily heparin injections. The study enrolls people who have given birth and have one or more risk f…
Phase: PHASE3 • Sponsor: University of Calgary • Aim: Prevention
Last updated Jul 29, 2026 00:00 UTC
-
Can a blood vessel drug beat aspirin at preventing heart attacks in diabetes?
Prevention Recruiting nowThis trial compares two blood-thinning drugs—aspirin and cilostazol—to see which one better prevents major heart and blood vessel events in people with type 2 diabetes who are already at high risk. About 1,200 participants will be randomly assigned to take one of the two medicati…
Phase: PHASE4 • Sponsor: Seoul National University Bundang Hospital • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Postpartum blood pressure control may stop preeclampsia from leading to lifelong hypertension
Prevention Recruiting nowThis trial tests whether starting intensive blood pressure medication soon after childbirth can prevent chronic hypertension in women who had preeclampsia. Participants are randomly assigned to receive nifedipine ER when their blood pressure reaches different thresholds during th…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Could pregnant women safely stop aspirin earlier? new trial investigates
Prevention Recruiting nowThis trial looks at whether pregnant women at high risk for preeclampsia can safely stop taking daily aspirin at 24-28 weeks instead of continuing until 36 weeks. Around 300 women will be randomly assigned to either stop or continue aspirin. The goal is to see if stopping early l…
Phase: NA • Sponsor: St. Olavs Hospital • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
Shockwave before heart valve procedure may prevent bleeding in hardened arteries
Symptom relief Recruiting nowThis study tests whether using shockwave therapy on the leg artery before a TAVR heart valve procedure can reduce bleeding and other complications. It involves 100 adults with severe aortic stenosis and heavily calcified arteries. The goal is to make the procedure safer by prepar…
Phase: NA • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Symptom relief
Last updated Aug 18, 2026 01:00 UTC
-
Warm legs, better steps? new study tests heat therapy for PAD
Symptom relief Recruiting nowThis study tests whether daily leg heat therapy can improve walking ability and quality of life in people with peripheral artery disease (PAD). About 106 adults over 50 with PAD will use special heated trousers for 90 minutes a day at home for 12 weeks. Researchers will measure c…
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Aug 18, 2026 01:00 UTC
-
New study tests online therapy to ease stress for parents of kids with RASopathies
Symptom relief Recruiting nowThis study tests whether Acceptance and Commitment Therapy (ACT), delivered through a smartphone app, can help caregivers of children with RASopathies (like Neurofibromatosis type 1 and Noonan syndrome) cope with parenting stress. The trial is fully remote and involves 70 adult c…
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Hypnosis tested as a new tool to sharpen focus in brain injury and MS patients
Symptom relief Recruiting nowThis study explores whether hypnosis can help people with stroke, traumatic brain injury, or multiple sclerosis improve their attention and reduce fatigue. About 48 participants will receive hypnosis sessions alongside standard care, while researchers monitor brain activity with …
Phase: NA • Sponsor: Luzerner Kantonsspital • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Migraine drug rimegepant tested for safety in kids and teens
Symptom relief Recruiting nowThis study tests the long-term safety of rimegepant, a migraine medication taken as a dissolving tablet, in children and adolescents aged 6 to 18. About 600 participants with a history of migraine will take the drug as needed for up to one year. The main goal is to check for side…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can Brain-Triggered stimulation reawaken arms after stroke?
Symptom relief Recruiting nowThis study tests whether a smarter electrical stimulation device can help people recover arm and hand movement after a stroke. Participants with moderate arm weakness will be randomly assigned to receive either standard cyclic stimulation or a new EMG-triggered stimulation that r…
Phase: NA • Sponsor: MED-EL Elektromedizinische Geräte GesmbH • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New hope for kids with migraines: rimegepant enters final testing
Symptom relief Recruiting nowThis study tests whether rimegepant, a fast-dissolving tablet, can safely relieve migraine pain in children and adolescents aged 6 to 18. About 2,100 participants will receive either the drug or a placebo during a migraine attack. The main goal is to see if more kids become pain-…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could High-Intensity workouts and diet tame chest pain from tiny heart vessels?
Symptom relief Recruiting nowThis trial tests whether a 24-week personalized program called MICROFIT—combining high-intensity interval training with a personal trainer and Mediterranean-style dietary advice—is feasible for people with microvascular coronary dysfunction, a condition where small heart blood ve…
Phase: NA • Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can an unapproved device ease symptoms? a trial puts it to the test.
Symptom relief Recruiting nowThis trial investigates whether an experimental, unapproved medical device can help relieve symptoms in people with a specific condition. Researchers are enrolling participants to test the device's effects and safety. The goal is to see if this new approach could offer a drug-fre…
Phase: NA • Sponsor: Salvia BioElectronics • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New support program aims to boost CPAP use in stroke rehab
Symptom relief Recruiting nowThis study tests whether extra support—like personalized mask fitting, monthly phone calls, and a tracking app—helps stroke patients with sleep apnea use their CPAP machine more consistently during rehab. About 250 participants will be randomly assigned to either this intensive s…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Robot vs. visual training: which boosts stroke recovery more?
Symptom relief Recruiting nowThis study tests two advanced rehabilitation methods—robot-assisted walking training and visual feedback balance training—to see which better improves balance and walking in people who have had a stroke. About 60 adults with subacute or chronic stroke will participate in 4 weeks …
Phase: NA • Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Music as medicine? new study tests if tunes can heal stroke minds
Symptom relief Recruiting nowThis study explores whether listening to music on purpose, for one hour a day, can improve mental health in people who had a stroke at least six months ago. Sixty participants will be randomly assigned to listen to either music or an audiobook at home for four weeks. Researchers …
Phase: NA • Sponsor: New York University • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can a simple foot pump ease leg swelling in hospital patients?
Symptom relief Recruiting nowThis trial tests a device called the Pedal Pump, which moves the feet for 10 minutes to help reduce lower leg swelling (edema) in hospitalized patients. The study includes 60 adults with edema due to conditions like heart failure, kidney disease, or chronic venous insufficiency. …
Phase: NA • Sponsor: David McVay • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Coaching after stroke: a new path back to valued activities?
Symptom relief Recruiting nowThis trial tests whether Occupational Performance Coaching (OPC) can help adults who have had a stroke and finished rehabilitation get back to activities they value. Participants are randomly assigned to receive OPC or an attention control, both delivered virtually. The study mea…
Phase: NA • Sponsor: Queen's University • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Migraine drug tested for Long-Term safety in 1,000-Person trial
Symptom relief Recruiting nowThis phase 3 study evaluates the long-term safety of elismetrep (K-304), an oral medication taken as needed for migraine attacks. About 1,000 adults who previously took elismetrep in an earlier trial will continue using it intermittently. Researchers will track side effects over …
Phase: PHASE3 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Could a gentle brain zap boost stroke arm recovery?
Symptom relief Recruiting nowThis study tests whether adding a mild brain stimulation technique (tDCS) to a standard arm therapy (constraint-induced therapy) helps people who had a stroke more than therapy alone. Forty adults with chronic stroke and mild-to-moderate arm weakness will be randomly assigned to …
Phase: NA • Sponsor: Universidade do Estado do Pará • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Sleep app may boost stroke recovery
Symptom relief Recruiting nowThis study tests whether a digital program called Sleepio, which uses cognitive behavioral therapy for insomnia, can improve sleep in stroke survivors. Researchers will also see if better sleep helps with learning motor skills overnight. About 100 adults who have had a stroke and…
Phase: NA • Sponsor: University of Oxford • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Could a gentle brain zap help stroke survivors think clearly again?
Symptom relief Recruiting nowThis study tests whether a gentle electrical current applied to the scalp (tDCS) combined with computer-based cognitive training can improve memory, attention, and thinking in people who had a mild stroke. About 60 participants will receive either real tDCS or a sham (fake) versi…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
VR home therapy could boost stroke arm recovery
Symptom relief Recruiting nowThis study tests whether virtual reality (VR) training in a simulated home environment can improve arm and hand function in people recovering from a stroke. Researchers will compare VR-based task-oriented training to standard therapy in 86 participants. They will also use brain s…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New study to see if laser or energy therapy beats traditional hemorrhoid surgery for pain and recovery
Symptom relief Recruiting nowThis study will compare three surgical treatments for severe internal hemorrhoids: laser, energy therapy, and traditional surgery. About 60 adults with grade III hemorrhoids will choose their preferred treatment. The goal is to see which method provides less pain after surgery an…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New device zaps migraines away in Drug-Resistant patients
Symptom relief Recruiting nowThis study tests a device called the PRIMUS System that uses mild electrical pulses to stimulate nerves in the head and neck. It is for people with chronic or frequent migraine who have not gotten relief from at least three preventive medicines. The goal is to see if the device s…
Phase: NA • Sponsor: Salvia BioElectronics • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
New pill could help PAD patients walk longer without pain
Symptom relief Recruiting nowThis study tests a once-daily pill called orforglipron in about 1205 people with peripheral artery disease (PAD) who have leg pain when walking. The goal is to see if the drug helps them walk farther without pain and improves their quality of life. Participants will be followed f…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
New study tests safer tourniquet release for hypertensive surgery patients
Symptom relief Recruiting nowThis study compares two methods of releasing a tourniquet (a tight band that stops blood flow) during arm surgery in patients with high blood pressure. The goal is to see which method causes less of a sudden drop in blood pressure. The trial will include 68 adults whose blood pre…
Phase: NA • Sponsor: Kasr El Aini Hospital • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New migraine pill aims to stop pain in 2 hours – major trial underway
Symptom relief Recruiting nowThis study tests a new drug, elismetrep, to see if it can quickly stop migraine pain and bothersome symptoms like nausea or light sensitivity. About 1800 adults with frequent migraines will receive either the drug or a placebo. The main goal is to measure how many people are pain…
Phase: PHASE3 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Could a new suction technique help comatose patients breathe easier?
Symptom relief Recruiting nowThis trial tests whether a new method of clearing mucus from the airways—using intermittent suction through a breathing tube—works better than the standard continuous suction method in comatose patients who have had a stroke. About 600 participants will be randomly assigned to on…
Phase: NA • Sponsor: Affiliated Hospital of Nantong University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Mind over motion: new therapy boosts stroke rehab
Symptom relief Recruiting nowThis study tests whether adding action observation (watching movements) and motor imagery (imagining movements) to standard physical therapy can improve balance, daily function, and quality of life in people who had a stroke within the last year. About 56 participants will be ass…
Phase: NA • Sponsor: Karamanoğlu Mehmetbey University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New study seeks best pain block for heart surgery patients
Symptom relief Recruiting nowThis study compares two types of nerve blocks (ESPB and SPSIPB) to see which provides better pain relief after coronary artery bypass surgery. About 64 adults aged 45-85 will receive one of the blocks before surgery, and their pain levels, opioid use, and recovery speed will be t…
Phase: NA • Sponsor: Kutahya Health Sciences University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can rehab at home help stroke survivors regain arm function?
Symptom relief Recruiting nowThis study tests whether a home-based telerehabilitation program, using games, exercises, and video calls with therapists, can improve arm function and reduce disability in people who had a stroke 90-150 days ago. 202 participants will be randomly assigned to receive telerehabili…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can a smartphone app ease anxiety and depression in stroke survivors?
Symptom relief Recruiting nowThis study is testing a mobile app called MAYA that provides cognitive behavioral therapy (CBT) to help adults who have had a stroke manage anxiety and depression. About 10 participants aged 40-79 will use the app and provide feedback on how easy and helpful it is. The goal is to…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can a tiny zing to the fingers reboot the brain after stroke?
Symptom relief Recruiting nowThis trial tests whether a non-invasive electrical stimulation applied to specific acupoints on the fingers can improve memory, attention, and decision-making in people who have had a stroke. Adults aged 35 to 80 with mild to moderate cognitive impairment after an ischemic stroke…
Phase: NA • Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Could a pill calm Post-Stroke muscle spasms? new trial investigates
Symptom relief Recruiting nowThis phase 2 trial tests whether an oral drug called BMS-986368 can reduce spasticity—muscle tightness and spasms—in adults who had a stroke 4 to 18 months ago. The drug works by boosting natural compounds in the body that calm overactive nerves. Researchers will measure changes …
Phase: PHASE2 • Sponsor: Alberto Esquenazi • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
Symptom relief Recruiting nowThis pilot study tests whether taking melatonin at night can increase REM sleep and improve cognitive function in people with cirrhosis who have a complication called hepatic encephalopathy (HE). Participants take melatonin for one month and a control supplement (thiamine) for an…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Less therapist time, same recovery? a new stroke rehab approach puts Self-Supervised therapy to the test
Symptom relief Recruiting nowThis trial tests a partially self-supervised version of constraint-induced movement therapy (sCIMT) for adults with arm and hand weakness after a stroke. Over two weeks, participants complete up to 30 hours of therapy, with about one-third guided by a therapist and two-thirds don…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Singing together after stroke: a prescription for healing?
Symptom relief Recruiting nowThis trial tests whether six months of group singing can improve mood, quality of life, and language recovery in stroke survivors with aphasia, while also supporting their personal caregivers. Half of the participants will attend weekly singing sessions; the other half will recei…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Morning boost: a simple routine may help beat Post-Stroke depression
Symptom relief Recruiting nowThis pilot trial tests whether a six-week behavioral program focused on morning activation can improve mood and daily functioning in adults who have had a stroke and struggle with depressive symptoms. Participants are randomly assigned to either the morning activation program or …
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
A simple lesson before discharge could ease the heavy load on family caregivers
Symptom relief Recruiting nowThis study tests whether giving caregivers of palliative care patients a single training session on using a PEG feeding tube before the patient leaves the hospital can lower the caregivers' burden, stress, and improve their quality of life. Researchers will compare trained caregi…
Phase: NA • Sponsor: Uludag University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Massive study to track Real-World safety of new blood disorder drugs
Knowledge-focused Recruiting nowThis study is collecting long-term safety and effectiveness data on treatments for various blood disorders, including hemophilia, sickle cell disease, and clotting disorders. It aims to enroll 3000 people of any age with these conditions. Researchers will monitor side effects, co…
Sponsor: American Thrombosis and Hemostasis Network • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Massive malaria study aims to unlock secrets of infection in mothers and kids
Knowledge-focused Recruiting nowThis large observational study in Mali is following up to 15,000 pregnant women and children to understand why some get malaria and others don't. Researchers are looking at immune responses, parasite features, and other factors that influence infection and disease severity. The g…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
New Low-Energy MRI could make heart scans safer for people with metal implants
Knowledge-focused Recruiting nowThis study is testing a new type of MRI scanner that uses less energy than standard machines. The goal is to see if it can still take clear pictures of the heart, which could help people with metal devices in their body. Healthy volunteers and people with heart disease will have …
Phase: NA • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Scientists hunt for genetic clues in Virus-Linked cancers
Knowledge-focused Recruiting nowThis study collects tissue and blood samples from adults with HIV, other immune disorders, or cancers thought to be caused by viruses. Researchers will compare genes in cancer tissue to normal tissue to find genetic changes that drive these cancers. The goal is to better understa…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Major stroke study aims to unlock secrets of brain attacks
Knowledge-focused Recruiting nowThis study is for adults 18 and older who have had a stroke or a transient ischemic attack (TIA), often called a mini-stroke. The goal is to collect information from standard medical tests and some extra research tests, like blood draws and brain scans, to better understand how t…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Massive study aims to unlock secrets of rare vascular diseases
Knowledge-focused Recruiting nowThis study is collecting medical data and biological samples from people with genetic conditions affecting the heart and blood vessels, their relatives, and healthy volunteers. The goal is to better understand these diseases, improve diagnosis, and lay the groundwork for future t…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Can your education and background protect your brain after a stroke?
Knowledge-focused Recruiting nowThis study looks at how social and lifestyle factors—like education, race, and income—affect a person's thinking and memory after a stroke. Researchers will interview 450 adults who had a stroke and review their brain scans and medical records. The goal is to understand why some …
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Massive study aims to unlock mysteries of rare blood vessel disease
Knowledge-focused Recruiting nowThis study follows up to 4,000 people with vasculitis (a group of diseases that cause blood vessel inflammation) and healthy volunteers over many years. Researchers collect blood, urine, imaging, and genetic samples to learn how the disease develops and changes. The goal is to fi…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Massive heart study seeks 5,000 volunteers to uncover hidden risks
Knowledge-focused Recruiting nowThis study aims to learn more about heart and blood vessel diseases by observing people who have them or are at risk. Researchers will collect samples and perform tests like imaging and stress tests on up to 5,000 participants, including healthy volunteers and relatives of affect…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
NIH launches Long-Term study to uncover clues in rare lung disease
Knowledge-focused Recruiting nowThis natural history study follows 270 adults with pulmonary arterial hypertension (PAH) and healthy volunteers to track how the disease changes over time. Researchers will use blood tests, heart and lung imaging, and a six-minute walk test to find new markers of disease severity…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Can immune cells heal the heart and brain after attack?
Knowledge-focused Recruiting nowThis study looks at how certain white blood cells, called monocytes, react to injury from a heart attack or ischemic stroke. Researchers want to learn how these cells sense danger signals and produce substances that might help heart muscle and brain tissue heal. The study involve…
Sponsor: UConn Health • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Sickle cell study aims to uncover disease patterns
Knowledge-focused Recruiting nowThis study follows up to 3,500 people with sickle cell disease to learn more about how the condition progresses and what complications arise. Participants receive their usual medical care outside the hospital and visit the clinic for check-ups and research tests. No experimental …
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
New study investigates why heart disease hits african americans differently
Knowledge-focused Recruiting nowThis study looks at how obesity and body fat affect heart disease risk in 2,000 healthy African American men and women. Researchers will measure body fat, blood fats, and insulin function to see if risk factors differ by sex. The goal is to understand why heart disease rates are …
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Gene hunt in peru: could ancestry hold key to autoimmune diseases?
Knowledge-focused Recruiting nowThis study aims to uncover genetic changes that cause autoimmune diseases in people native to Peru. Researchers will collect blood, urine, and stool samples from 300 participants, including patients with conditions like lupus and rheumatoid arthritis, their family members, and he…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Smart eye drop tracker aims to boost glaucoma treatment adherence
Knowledge-focused Recruiting nowThis study is testing a smart device called CONNECTDROP® that clips onto eye drop bottles to track how often glaucoma patients use their medication. About 200 adults with open-angle glaucoma will use the device and a smartphone app for one year. The goal is to see if the technolo…
Sponsor: Laboratoires Thea • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Can we stop early artery aging in kids with kidney disease?
Knowledge-focused Recruiting nowThis study investigates why arteries stiffen and harden faster in children and young people with chronic kidney disease (CKD) and high blood pressure. Researchers will use non-invasive tests to compare arterial stiffness between those with CKD and matched controls, including heal…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Blood test clues: could two proteins predict heart failure after a heart attack?
Knowledge-focused Recruiting nowThis study looks at whether two proteins released when heart muscle is damaged can be detected in the blood during a heart attack. Researchers want to see if higher levels of these proteins are linked to a greater chance of developing heart failure afterward. The study includes a…
Sponsor: UConn Health • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
A 30-Minute nailbed scan could reveal how lung treatments work
Knowledge-focused Recruiting nowThis study explores whether a simple, radiation-free scan of the nailbeds—called nailfold capillaroscopy—can help diagnose and monitor pulmonary hypertension (PH), a condition of high blood pressure in the lungs. Researchers will compare nailbed blood vessel measurements with inv…
Sponsor: University of Glasgow • Aim: Knowledge-focused
Last updated Aug 18, 2026 01:00 UTC
-
Can a new questionnaire give patients a stronger voice in vascular malformation care?
Knowledge-focused Recruiting nowThis study aims to develop a standardized questionnaire that lets patients with venous malformations report their own symptoms and treatment outcomes. Venous malformations are abnormal veins that can cause pain, swelling, and emotional distress, and current assessments may miss w…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Liver clues: a new way to stage heart amyloidosis?
Knowledge-focused Recruiting nowThis study looks at whether liver function and blood clotting tests can help doctors better understand and monitor cardiac transthyretin amyloidosis (ATTR-CA), a condition where abnormal protein builds up in the heart. Researchers will compare these tests in people with ATTR-CA a…
Sponsor: University of Messina • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can a nudge in your chart unlock Life-Saving genetic clues?
Knowledge-focused Recruiting nowThis study tests whether simple reminders—called nudges—sent to doctors and patients can increase the use of genetic testing for people with certain conditions like Parkinson's disease, ALS, or heart problems. The trial will compare different ways of prompting genetic testing, su…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can your daily steps predict your mood? new study investigates
Knowledge-focused Recruiting nowThis study looks at how physical activity, sleep, and light exposure relate to mood in people with bipolar disorder, major depression, or no mood disorder. Over two years, participants wear activity monitors and complete smartphone diaries for up to 20 days at a time. The goal is…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Could muscle loss predict stroke recovery?
Knowledge-focused Recruiting nowThis study investigates whether sarcopenia—age-related muscle loss—is common in older adults during the acute phase of ischemic stroke and whether it influences recovery. Researchers will assess muscle mass and function in 400 patients aged 50 and older within 72 hours of stroke …
Sponsor: University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Stroke shoulder pain study aims to uncover hidden impacts on recovery
Knowledge-focused Recruiting nowThis study looks at how shoulder pain on the paralyzed side after a stroke affects arm movement, trunk control, fear of falling, mobility, and independence. Researchers will assess 62 stroke survivors using standard tests and ultrasound. The goal is to better understand the relat…
Sponsor: Kutahya Health Sciences University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can a few short nights of sleep tip the scales toward high blood pressure?
Knowledge-focused Recruiting nowThis study looks at how partial sleep deprivation affects blood pressure in healthy young adults whose parents have high blood pressure compared to those whose parents have normal blood pressure. Participants will spend 10 days in a sleep lab, with some nights allowing only 5 hou…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Scientists launch major study to unravel rare genetic conditions
Knowledge-focused Recruiting nowThis study aims to learn more about RASopathies, a group of genetic conditions that can cause developmental issues, birth defects, and increased cancer risk. Researchers will follow up to 500 people of any age who have or may have a RASopathy, along with their family members, for…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New model aims to decode mysterious blood test results
Knowledge-focused Recruiting nowThis study is checking if a computer model can accurately predict why some people have a prolonged blood clotting time (APTT). The model uses data from routine blood tests to tell if the cause is harmless or a sign of a clotting disorder. Researchers will test it on 1,500 patient…
Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can we predict which heart aneurysms will grow?
Knowledge-focused Recruiting nowThis study looks back at the medical records of 1,000 people with coronary artery aneurysms—bulges in the heart's blood vessels. Researchers want to understand how these aneurysms change over time, what factors increase the risk of progression, and whether different treatment str…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can balloon timing make or break heart artery success?
Knowledge-focused Recruiting nowThis study tracks 500 adults with stable coronary artery disease or unstable angina who are undergoing a heart procedure called percutaneous coronary intervention (PCI) using a drug-coated balloon. Researchers are looking at how procedural details—specifically how long the balloo…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can a new CT scan see brain stents clearly enough to replace an invasive test?
Knowledge-focused Recruiting nowThis study tests whether a new type of CT scan, called ultra-high-resolution photon-counting CT angiography, can accurately check whether stents placed in the brain's venous sinuses are still open. It compares this new scan to the standard CT method and to the more invasive DSA p…
Sponsor: Xin Lou • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
NIH launches study to collect samples for future disease breakthroughs
Knowledge-focused Recruiting nowThis study collects blood and urine samples from healthy adults and patients with heart, lung, or blood vessel conditions. Researchers will use these samples to study genes, proteins, and other substances in the lab. The goal is to support basic and translational research that co…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can brain scans reveal why stroke disrupts Two-Handed learning?
Knowledge-focused Recruiting nowThis study investigates how a recent stroke affects the ability to learn new motor skills that require using both arms or hands together. Researchers will use robotic devices to measure learning and brain imaging to see which brain areas are involved. The goal is to understand wh…
Phase: NA • Sponsor: University Hospital of Mont-Godinne • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
5,000 heart patients to wear smart patches for Years-Long observation
Knowledge-focused Recruiting nowThis study will enroll 5,000 adults with chronic heart conditions like heart failure, high blood pressure, or aortic stenosis. Participants will wear a Prolaio digital health patch that monitors heart rate, breathing, and other vital signs. The goal is to observe how these condit…
Sponsor: Prolaio • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Wearable device could warn you before you faint
Knowledge-focused Recruiting nowThis study tests whether a wearable Holter monitor can detect early signs of fainting in people with orthostatic hypotension or reflex syncope. Forty adults who have already had a tilt-table test will wear the monitor for up to 21 days. The goal is to see if the device can pick u…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Computer prompts aim to prevent deadly clots in brain injury patients
Knowledge-focused Recruiting nowThis study tests whether a clinical decision support (CDS) system can help doctors follow best-practice guidelines for preventing venous thromboembolism (blood clots) in adults with traumatic brain injury. Researchers will compare hospitals that use the CDS system with those that…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Simple CT scan may replace invasive heart tests for millions
Knowledge-focused Recruiting nowThis study looks at whether a special CT scan (CT-FFR) can help doctors predict heart attacks and other serious events in people with chronic coronary syndrome. About 3,000 participants in China will be followed for up to 5 years. The goal is to see if abnormal CT-FFR results are…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can a robot unlock the Brain's recovery after stroke?
Knowledge-focused Recruiting nowThis study investigates whether people who recently had a stroke (within 21 days) can learn new arm movements using a rehabilitation robot called REAplan. Researchers will compare their learning ability with healthy individuals and those who had a stroke long ago. The goal is to …
Phase: NA • Sponsor: University Hospital of Mont-Godinne • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
New decision aid aims to ease tough choices for rare heart defect
Knowledge-focused Recruiting nowThis study is creating a decision aid for people with a rare heart condition called right anomalous aortic origin of a coronary artery (R-AAOCA). The condition raises the risk of sudden cardiac death, but the best management—surgery or careful observation—isn't clear. The aid wil…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New registry to monitor Real-World use of blood clot devices
Knowledge-focused Recruiting nowThis registry will follow 1000 adults with pulmonary embolism (blood clots in the lungs) who are treated with Inari Medical devices. Researchers will track device-related complications and deaths to understand how safe these tools are in everyday use. The study is observational, …
Sponsor: Inari Medical • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can migraine meds be safe while breastfeeding? a new study investigates
Knowledge-focused Recruiting nowThis study looks at how much of the migraine drug galcanezumab (Emgality) appears in breastmilk after a mother receives her usual injections. Researchers will measure drug levels in milk samples from 30 women with migraine who are breastfeeding, and also track infant growth, deve…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Could a free smartphone app replace the goniometer for stroke rehab?
Knowledge-focused Recruiting nowThis study checks whether a free smartphone app called PhysioMaster can reliably measure posture and range of motion in people who have had a stroke. Researchers will compare the app's measurements to those from standard tools like the universal goniometer. Sixty stroke survivors…
Sponsor: Istinye University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New heart drug enters early safety testing
Knowledge-focused Recruiting nowThis study is an early-stage trial to check the safety of a new drug called RO7763505. It involves 196 participants, first in healthy volunteers and then in people with stable coronary artery disease. The main goal is to see if the drug is safe and how the body processes it, not …
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New device for leg clots tested in first human survey
Knowledge-focused Recruiting nowThis study surveys doctors who use the Liberant system to remove fresh blood clots from leg arteries and veins. About 50 patients aged 22 or older will be treated within 72 hours of their procedure. The goal is to confirm the device is safe and works as intended.
Sponsor: Medtronic Endovascular • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
A fingertip sensor might foresee blood pressure crashes during spinal anesthesia
Knowledge-focused Recruiting nowThis study looks at whether a simple, non-invasive measure called the perfusion index (PI) can predict a sudden drop in blood pressure (hypotension) that often happens during spinal anesthesia for knee surgery. The PI, measured with a standard pulse oximeter on the finger, reflec…
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
AI and a pulse oximeter may predict dangerous blood pressure swings in spinal cord injury
Knowledge-focused Recruiting nowThis study explores whether a measure called perfusion index (PI), taken from a pulse oximeter on the ear, finger, or toe, can reliably predict changes in blood pressure in people with spinal cord injury (SCI) during a cool temperature challenge. Participants with SCI and healthy…
Phase: NA • Sponsor: James J. Peters Veterans Affairs Medical Center • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Which ventilator mode is best for heart patients? a pilot study aims to find out
Knowledge-focused Recruiting nowThis study tests whether it is possible to run a larger trial comparing two ways of using a breathing machine (ventilator) in critically ill heart patients who need help breathing. The two modes are volume-controlled (delivers a set amount of air each breath) and pressure-control…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Scientists launch major study to unravel mysterious metabolism disorders
Knowledge-focused Recruiting nowThis study aims to learn more about rare disorders that affect how the body processes chemicals called pyrimidines and purines. These disorders can cause problems in the brain, blood, kidneys, and immune system, ranging from mild to life-threatening. Researchers will compare test…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Brain drain antibiotic debate: short course may be enough
Knowledge-focused Recruiting nowThis study looks at whether giving antibiotics for just 24 hours around the time of placing a special antibiotic-coated brain drain works as well as giving them for the whole time the drain is in place. The goal is to find the best way to prevent serious brain infections in peopl…
Phase: PHASE1 • Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Could a symptom registry unmask hidden migraine variants?
Knowledge-focused Recruiting nowThis study is building a large online registry of US adults who experience sinus, ear, dizziness, and headache symptoms, with or without a migraine diagnosis. Participants answer questions about their symptoms, how these affect daily life, and which treatments they have tried. Th…
Sponsor: Association of Migraine Disorders • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Hidden heart condition may affect aortic stenosis outcomes – can imaging catch it?
Knowledge-focused Recruiting nowThis study looks at whether advanced imaging can detect a hidden heart condition called cardiac amyloidosis in people with severe aortic valve stenosis. The condition can complicate treatment and recovery. Researchers will use echocardiography, CT, and SPECT/CT scans to check for…
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Scientists seek tissue samples to unlock HIV and cancer mysteries
Knowledge-focused Recruiting nowThis study collects blood, bone marrow, and tissue samples from people with HIV, KSHV, or certain cancers to help researchers learn more about these diseases. Participants must be 18 or older and may have HIV, KSHV, or related conditions. No treatment is given; the goal is to gat…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Can 4D-MRI spot brain aneurysms before they rupture?
Knowledge-focused Recruiting nowThis study is testing whether a special MRI technique, called 4D Flow MRI, can better detect and predict the growth of unruptured brain aneurysms. Researchers will follow adults with these aneurysms, using the advanced imaging to measure changes in the aneurysm's shape over time.…
Phase: NA • Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could low blood pressure be a hidden cause of thinking problems in Parkinson's?
Knowledge-focused Recruiting nowThis study looks at how blood pressure changes when standing affect thinking and brain blood flow in people with Parkinson's disease. About 60 participants, with and without orthostatic hypotension (low blood pressure on standing), will take thinking tests while lying down and st…
Phase: NA • Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Scientists probe immune System's role in chronic disease
Knowledge-focused Recruiting nowThis study looks at how the body's innate immune system responds to certain environmental exposures by measuring inflammation markers in blood. Researchers will collect blood samples from up to 725 healthy volunteers aged 18-45 to analyze how specific genes and proteins react. Th…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Artery plaque scans may reveal hidden stroke risk
Knowledge-focused Recruiting nowThis study investigates whether high-resolution MRI can identify dangerous plaque features in the middle cerebral artery that might predict a second stroke. Researchers will follow 75 patients who had a first stroke due to significant narrowing of this artery, tracking which plaq…
Sponsor: University Medical Center Ho Chi Minh City (UMC) • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Massive study aims to unravel mysteries of blood clots and vessel disease
Knowledge-focused Recruiting nowThis study aims to learn more about how diseases related to blood clots, the immune system, and blood vessels start and change over time. Researchers will enroll up to 1,000 people aged 5 and older, including those with these conditions, their healthy relatives, and healthy volun…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Researchers check safety of stent grafts used in aortic aneurysm surgery
Knowledge-focused Recruiting nowThis study looks back at medical records of 105 people who had a minimally invasive surgery called BEVAR to treat complex aortic aneurysms. Researchers want to see if two types of stent grafts (TUVA BX and iCover) are safe and work well. No new treatments are given; the study jus…
Sponsor: JOTEC GmbH • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Massive study launches to unravel mysteries of rare lymphatic diseases
Knowledge-focused Recruiting nowThis natural history study aims to collect data from 1,200 people with lymphatic anomalies—rare conditions affecting the body's lymph system—over many years. Researchers will track symptoms, perform genetic testing, and gather biospecimens to better understand why these condition…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can Real-World data improve stroke recovery?
Knowledge-focused Recruiting nowThis study follows adults who have had a stroke caused by a blockage in a medium-sized blood vessel in the brain. Researchers will track the treatments patients receive and their recovery over time. The goal is to learn which approaches work best in everyday practice, helping doc…
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Eye ultrasound may reveal brain risks during heart surgery
Knowledge-focused Recruiting nowThis study will compare two types of heart-lung machines used during coronary bypass surgery to see how they affect blood flow to the brain. Researchers will measure brain pressure using an eye ultrasound and brain oxygen levels with a forehead sensor in 70 patients. The goal is …
Sponsor: Kartal Kosuyolu High Speciality Training and Research Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can eye scans reveal hidden clues about diabetes damage?
Knowledge-focused Recruiting nowThis study uses a special eye imaging technique called OCT angiography to look at tiny blood vessels in the retina of people with diabetic retinopathy. Researchers will measure vessel density and other vascular features, then check whether these relate to visual sharpness and blo…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can we unlock the secrets to stroke prevention in africa?
Knowledge-focused Recruiting nowThis study aims to gather crucial information about stroke in Uganda, where the disease is on the rise. Researchers will look at how common stroke is, what factors increase the risk, and how it affects people's quality of life. The goal is to identify what rehabilitation support …
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Should you pause your blood pressure pills before surgery? new study investigates
Knowledge-focused Recruiting nowThis study looks at whether stopping certain blood pressure medications (ACE inhibitors or ARBs) before colorectal cancer surgery can reduce the risk of heart injury. Researchers will monitor 156 adults for signs of heart damage after surgery. The goal is to find the safest way t…
Phase: PHASE3 • Sponsor: Kasr El Aini Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New MRI techniques aim to spot heart disease without radiation
Knowledge-focused Recruiting nowThis study is testing new magnetic resonance imaging (MRI) techniques to get clearer pictures of the heart and blood vessels without using radiation. Researchers will compare these new MRI methods to standard tests like angiography and CT scans. Up to 4,000 adults—including healt…
Phase: NA • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
New study aims to set normal clotting values for kids using a rapid test
Knowledge-focused Recruiting nowThis study looks at how well a rapid blood test called TEG 6s measures clotting in healthy children. About 125 kids having planned surgery will give a small blood sample for the test. The goal is to find normal values for children and compare them to existing ranges. No treatment…
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Could a placental protein unlock the mystery of preeclampsia?
Knowledge-focused Recruiting nowThis study investigates whether certain progesterone receptors in the placenta are linked to preeclampsia, a serious pregnancy condition marked by high blood pressure. Researchers will compare placental tissue from women with preeclampsia to that from healthy pregnant women, meas…
Sponsor: Samsun University • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
NIH launches study to uncover genetic roots of Hormone-Driven high blood pressure in black communities
Knowledge-focused Recruiting nowThis study aims to find the genetic causes of primary aldosteronism, a condition where adrenal tumors cause high blood pressure, in Black individuals. Researchers will enroll 1150 participants, including those with difficult-to-control blood pressure or known primary aldosteronis…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
NIH launches major study to unravel genetic metabolic mysteries
Knowledge-focused Recruiting nowThis study aims to better understand and treat people with certain inherited metabolic or genetic disorders. Researchers will use standard medical tests like blood work and imaging to diagnose and care for participants, who may also join other related studies. The goal is to expa…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Scientists launch Decade-Long quest to unravel rare stroke disorder
Knowledge-focused Recruiting nowThis study follows 155 adults with CADASIL, a genetic condition that narrows small blood vessels and raises the risk of strokes and dementia, over nine years. Researchers will use brain scans, blood tests, and other exams to track how the disease changes blood vessels and thinkin…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
New MRI study aims to sharpen heart imaging and check for gadolinium traces
Knowledge-focused Recruiting nowThis study aims to develop better MRI methods for imaging the heart and brain, and to describe heart diseases using these new techniques. It will also investigate whether gadolinium, a common MRI contrast agent, stays in the body long after use. Up to 5,000 healthy volunteers and…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
UK study counts how many preterm babies get eylea for eye disease
Knowledge-focused Recruiting nowThis observational study collects data from UK preterm babies with retinopathy of prematurity (ROP) who are treated with the drug aflibercept (Eylea) using a paediatric dosing device. The main goal is to count how many babies receive this treatment and decide if there are enough …
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can a drop of blood predict disease years before it strikes?
Knowledge-focused Recruiting nowThis study is collecting blood samples and health data from 15,000 symptom-free adults over 40 to understand what healthy aging looks like at the molecular level. By tracking participants over time, researchers hope to establish normal ranges for thousands of blood markers and id…
Sponsor: Center for Molecular Fingerprinting Research Nonprofit LLC • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can job frustration raise your blood pressure? a new study aims to find out
Knowledge-focused Recruiting nowThis study explores whether work-related frustration and stress are linked to higher-risk blood pressure patterns, such as masked or white-coat hypertension. Researchers will monitor the blood pressure of working adults aged 40 to 65 over 24 hours and compare it with their percei…
Sponsor: University of Burgundy • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Stroke recovery: could a simple physical exam reveal hidden clues about energy and heart health?
Knowledge-focused Recruiting nowThis study investigates whether physical exam findings called somatic dysfunction — impaired function of the body's framework — can be linked to energy expenditure, heart rate variability, and quality of life in people who have had a stroke. Researchers will assess 100 chronic st…
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Could tailored blood thinner dosing prevent strokes in chinese patients?
Knowledge-focused Recruiting nowThis study looks at how blood levels of common blood thinners (apixaban, dabigatran, edoxaban, and rivaroxaban) change over time in Chinese patients with atrial fibrillation. Researchers will take blood samples before and after stopping the medication for medical procedures. The …
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
A rare bleeding disorder under the microscope: what can a patient registry reveal?
Knowledge-focused Recruiting nowThis study creates a detailed registry of people with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels and bleeding. Researchers will track participants over time to collect information on symptoms, treatments, and disease progression. T…
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Depression drug may mend blood vessels damaged by preeclampsia
Knowledge-focused Recruiting nowWomen who had preeclampsia are at higher risk for both depression and heart disease later in life. This study investigates whether antidepressant medication can improve blood vessel function in these women. Researchers will measure skin blood vessel responses in 40 women, compari…
Phase: EARLY_PHASE1 • Sponsor: Anna Stanhewicz, PhD • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Heart rehab may tweak cell death pathways — a study investigates
Knowledge-focused Recruiting nowThis study examines whether a structured cardiac rehabilitation program — including exercise, education, and lifestyle changes — can influence ferroptosis, a form of regulated cell death, in people with coronary artery disease. Researchers will compare gene expression and blood m…
Phase: NA • Sponsor: TC Erciyes University • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Thigh muscle scans may reveal hidden muscle loss after stroke
Knowledge-focused Recruiting nowThis study investigates whether ultrasound measurements of thigh muscle thickness can help detect sarcopenia (muscle loss) and fear of movement in people who have had an ischemic stroke. Researchers will compare ultrasound results with standard tests like handgrip strength and a …
Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Could a wireless patch replace wires on tiny heads? a NICU trial puts it to the test
Knowledge-focused Recruiting nowThis study tests whether a wireless sensor placed on the forehead can accurately measure oxygen levels in the brains of infants in the neonatal intensive care unit (NICU). The wireless device is compared side-by-side with the standard wired monitor in 20 newborns with conditions …
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Eye scan may spot hidden blood-flow changes that signal glaucoma risk in diabetes
Knowledge-focused Recruiting nowThis observational study uses a painless, non-invasive eye scan called iris OCTA to measure blood flow in the iris of people with type 2 diabetes. Researchers want to see if blood-flow patterns differ between healthy eyes, diabetic eyes without complications, and those with diabe…
Sponsor: Qilu Hospital of Shandong University • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Eye-Opening clue: ultrasound of the optic nerve may predict spinal headache after C-Section
Knowledge-focused Recruiting nowThis study tests whether measuring the optic nerve sheath diameter with ultrasound can predict post-dural puncture headache (PDPH) in women undergoing elective cesarean delivery under spinal anesthesia. Researchers will also monitor brain oxygen levels to see if drops in oxygen r…
Sponsor: Ordu University • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Tiny particles in blood may signal hidden heart risk in hypertensive children
Knowledge-focused Recruiting nowThis study investigates whether microscopic particles shed from blood vessels, called endothelial extracellular vesicles, can serve as early warning signs of blood vessel damage in children with newly diagnosed, untreated high blood pressure. Researchers will compare these partic…
Sponsor: Josip Juraj Strossmayer University of Osijek • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Hidden heart risks in testicular cancer survivors: a closer look at chemotherapy's long shadow
Knowledge-focused Recruiting nowThis study investigates whether testicular cancer survivors who received cisplatin-based chemotherapy and bone marrow transplant have hidden heart disease that standard checkups might miss. Researchers will use advanced blood tests and CT scans to measure cholesterol, plaque in t…
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Tiny particles in the blood may warn of dangerous pregnancy high blood pressure
Knowledge-focused Recruiting nowThis study looks at whether tiny particles shed from blood vessels, called endothelial extracellular vesicles, can serve as early warning signs for hypertensive disorders of pregnancy, such as preeclampsia. Researchers will compare levels of these particles in pregnant women with…
Sponsor: Josip Juraj Strossmayer University of Osijek • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Tiny particles in the blood may signal early vessel damage from high blood pressure
Knowledge-focused Recruiting nowThis study compares levels of tiny particles shed from blood vessels in people with newly diagnosed, untreated high blood pressure versus those with normal blood pressure. Researchers want to see if these particles can serve as early, non-invasive markers of blood-vessel injury. …
Sponsor: Josip Juraj Strossmayer University of Osijek • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Ultrasound after a first c-section may reveal hidden scar risks
Knowledge-focused Recruiting nowThis study uses transvaginal ultrasound to examine the uterine scar in women who have had a single cesarean section. Researchers aim to identify factors linked to a condition called a 'niche'—a small pocket in the scar that can cause symptoms like pelvic pain or abnormal bleeding…
Sponsor: Medical University of Gdansk • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
AI reads blood flow to predict if heart stents will work
Knowledge-focused Recruiting nowThis study tests whether a machine learning model can predict the outcome of a common heart procedure — placing a stent to open a hardened, calcified artery. Researchers will measure blood flow and pressure before and after the procedure in 100 adults with coronary artery disease…
Sponsor: Aalborg University Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can tracking thousands of dementia cases reshape how we care for patients?
Knowledge-focused Recruiting nowThis study follows 5,000 people with mild cognitive impairment or mild-to-moderate dementia living at home in Bavaria, along with their family caregivers. Researchers collect detailed information on health, daily function, care needs, and quality of life over several years. The g…
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can closing a hole in the heart prevent future strokes? a long-term study seeks answers.
Knowledge-focused Recruiting nowThis study tracks 400 people who had a procedure to close a patent foramen ovale (PFO), a small hole between the heart's upper chambers that can raise stroke risk. Researchers want to see how often strokes or mini-strokes return, whether a residual shunt persists, and what factor…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Could the gut hold the key to calming autoinflammatory Flare-Ups?
Knowledge-focused Recruiting nowThis study investigates whether gut bacteria and the chemicals they produce influence inflammation in people with autoinflammatory diseases such as FMF, CAPS, and MKD. Researchers will analyze stool and blood samples from 300 patients to measure gut-derived metabolites and assess…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?
Knowledge-focused Recruiting nowThis study is testing whether a non-invasive eye scan called optical coherence tomography (OCT) can help track neurological diseases like multiple sclerosis, Alzheimer's, Parkinson's, and migraine. Over two years, researchers will measure the thickness of retinal layers in 840 pa…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Does longer time on Heart-Lung machine mean longer ICU stay?
Knowledge-focused Recruiting nowThis study examines whether the duration a patient spends on cardiopulmonary bypass (heart-lung machine) and with the aorta clamped during coronary artery bypass surgery is linked to how long they stay in the intensive care unit afterward. Researchers will review medical records …
Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New risk score could predict strokes in heart patients despite blood thinners
Knowledge-focused Recruiting nowThis study aims to create a better way to predict stroke risk in people with atrial fibrillation (an irregular heartbeat) who are already taking direct oral anticoagulants (DOACs), a type of blood thinner. Even with these medications, some patients still have strokes. Researchers…
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Massive asian TAVR registry aims to unlock secrets of long-term valve success.
Knowledge-focused Recruiting nowThis study is a large registry that collects data from thousands of patients across Asia who have undergone transcatheter aortic valve replacement (TAVR) for severe aortic stenosis. Researchers will analyze medical records to see how well the valves perform over time and what fac…
Sponsor: Eunpyeong St. Mary's Hospital • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Robot reveals hidden patterns in arm recovery after stroke
Knowledge-focused Recruiting nowThis study uses a special robot called IntelliArm to measure how arm stiffness, spasticity, and movement change during recovery from a first stroke. Researchers will track 56 people who had a stroke less than a month ago, measuring their arm function with standard tests and robot…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Ultrasound clue vanishes days after steroids start in artery disease
Knowledge-focused Recruiting nowThis study tracks how fast the 'halo sign' — a key ultrasound marker of inflamed arteries — disappears after starting steroid treatment in people with giant cell arteritis, a rare disease that can cause blindness. Researchers will scan the temporal arteries of 64 newly diagnosed …
Phase: NA • Sponsor: Centre Hospitalier le Mans • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Massive HHT registry aims to unlock secrets of rare bleeding disorder
Knowledge-focused Recruiting nowThis study creates a large registry of people diagnosed with hereditary hemorrhagic telangiectasia (HHT), a condition causing abnormal blood vessels and bleeding. Researchers will collect medical records and annual health updates for up to 10 years to understand how the disease c…
Sponsor: Cure HHT • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
AI and ultrasound join forces to spot muscle wasting in Brain-Injured ICU patients
Knowledge-focused Recruiting nowThis study tests whether artificial intelligence can predict muscle loss (sarcopenia) in intensive care patients with serious brain conditions like stroke, bleeding, or tumors. Researchers will measure thigh muscle thickness with ultrasound and track nutrition markers over the fi…
Sponsor: Trabzon Kanuni Education and Research Hospital • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Brain scans could reveal hidden stroke risk in artery disease patients
Knowledge-focused Recruiting nowThis study looks at whether special MRI scans can help predict which people with severe narrowing of brain arteries (70-99% stenosis) are most likely to have another stroke. Participants have already had a minor stroke and are enrolled in a larger treatment trial. They will get a…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Interactive game tracks stroke recovery to personalize rehab
Knowledge-focused Recruiting nowThis study follows 100 stroke survivors over six months to understand how sitting balance, standing balance, and walking recover. Using wearable sensors and an interactive assessment game, researchers measure movement, coordination, and reaction time. The goal is to identify reco…
Sponsor: Vrije Universiteit Brussel • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Unlocking hand recovery: how assistive devices reshape muscle coordination after stroke
Knowledge-focused Recruiting nowThis study investigates how two types of assistive devices—exotendon and end-effector—affect finger extension and muscle coordination in 15 chronic stroke survivors and 15 healthy adults. Participants perform finger movements with and without assistance while muscle activity is r…
Phase: EARLY_PHASE1 • Sponsor: The Catholic University of America • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Registry aims to uncover long-term outlook for rare blood-clot lung disease
Knowledge-focused Recruiting nowThis study follows people with chronic thromboembolic disease (CTD) or chronic thromboembolic pulmonary hypertension (CTEPH) — conditions where blood clots scar the lungs' blood vessels. Researchers track survival, exercise ability, oxygen use, and quality of life over time using…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC